ID

DB00245|APRD00748||

名称

Benzatropine

描述

Benztropine, with the chemical formula 3alpha-diphenylmethoxytropane, is a tropane-based dopamine inhibitor used for the symptomatic treatment of Parkinson's disease. It is a combination molecule between a tropane ring, similar to cocaine, and a diphenyl ether from the dialkylpiperazines determined to be a dopamine uptake inhibitor since 1970. The generation of structure-activity relationships proved that benztropine derivatives with the presence of a chlorine substituent in the para position in one of the phenyl rings produces an increased potency for dopamine uptake inhibition as well as a decreased inhibition of serotonin and norepinephrine.[A37914] Benztropine was developed by USL Pharma and officially approved by the FDA on 1996.[L5500]

cas号

86-13-5

唯一标识码

1NHL2J4X8K

状态

solid

组

approved,

指示

Benztropine is indicated to be used as an adjunct in the therapy of all forms of parkinsonism. It can also be used for the control of extrapyramidal disorders due to neuroleptic drugs.[T203] The extrapyramidal symptoms are defined as drug-induced disorders that include symptoms of dystonia, akathisia, parkinsonism, bradykinesia, tremors, and dyskinesia.[A175120] Parkinsonism is a general term that refers to the group of neurological disorders that produce symptoms similar to Parkinson's disease such as tremors, slow movement, and stiffness. The parkinsonism includes a large number of disorders and some of them have not been clearly defined.[L5509]

药效学

The inhibition of dopamine reuptake by benztropine produces a dose-dependent increase of dopamine in the nerve terminal of the dopaminergic system.[A1628] Clinically the activity of benztropine is observed after 1-2 hours of oral administration and after a few minutes of intramuscular administration with a last-longing effect of about 24 hours. Reports have indicated that benztropine has a very large sedative effect.[A1628] The antihistaminic effect of benztropine is very similar to the effect found in [pyrilamine] and the anticholinergic activity was found to be equal to [atropine] _ex vivo_ and of about 50% activity _in vivo_.[F3679]

作用机制

Benztropine is an agent with anti-muscarinic and antihistaminic effects. Its main mechanism of action is presented by the selective inhibition of dopamine transporters but it also presents affinity for histamine and muscarine receptors.[A175084] It is widely known that benztropine is a potent inhibitor of presynaptic carrier-mediated dopamine transport. As well, it is known to be an analog of atropine and hence, it has a large affinity for muscarinic receptors M1 in the human brain. Once bound, benztropine blocks the activity of the muscarinic receptors mainly in the striatum.[A1628] The increased advantage of benztropine lays on the antagonism of acetylcholine activity which corrects the imbalance between dopamine and acetylcholine in Parkinson patients.[F3679]

毒性

The oral LD50 of benztropine is reported to be of 940 mg/kg in rats.[MSDS] In the presence of overdose with benztropine, it has been observed symptoms of circulatory collapse, cardiac arrest, respiratory depression, respiratory arrest, psychosis, shock, coma, seizure, ataxia, combativeness, anhidrosis, hyperthermia, fever, dysphagia, decreased bowel sounds and sluggish pupils.[F3682]

代谢

Benztropine has been shown to undergo metabolism mainly marked by N-oxidation, N-dealkylation and ring hydroxylation.[A175087] The extensive metabolism of benztropine produces eight phase-I metabolites plus four glucuronide conjugates.[A1628]

吸收

Oral administration of 1.5 mg of benztropine is slowly absorbed in the gastrointestinal tract and it reaches a peak concentration of 2.5 ng/ml in about 7 hours.[A175087] It has an approximate oral bioavailability of 29%.[T445]

半衰期

The elimination half-life of benztropine is very variable and it is reported to be of around 36 hours.[F3682]

分类

description:This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.
direct-parent:Diphenylmethanes
kingdom:Organic compounds
superclass:Benzenoids
class:Benzene and substituted derivatives
subclass:Diphenylmethanes
alternative-parent:Azacyclic compounds
alternative-parent:Benzylethers
alternative-parent:Dialkyl ethers
alternative-parent:Hydrocarbon derivatives
alternative-parent:N-alkylpyrrolidines
alternative-parent:Organopnictogen compounds
alternative-parent:Piperidines
alternative-parent:Trialkylamines
alternative-parent:Tropane alkaloids
substituent:Amine
substituent:Aromatic heteropolycyclic compound
substituent:Azacycle
substituent:Benzylether
substituent:Dialkyl ether
substituent:Diphenylmethane
substituent:Ether
substituent:Hydrocarbon derivative
substituent:N-alkylpyrrolidine
substituent:Organic nitrogen compound
substituent:Organic oxygen compound
substituent:Organoheterocyclic compound
substituent:Organonitrogen compound
substituent:Organooxygen compound
substituent:Organopnictogen compound
substituent:Piperidine
substituent:Pyrrolidine
substituent:Tertiary aliphatic amine
substituent:Tertiary amine
substituent:Tropane alkaloid

消除途径

Benztropine is mainly excreted in the urine but it is also found in the feces unchanged.[A1628]

种类

Agents producing tachycardia

Alkaloids
D000470
Anti-Dyskinesia Agents
D018726
Anti-Parkinson Drugs
D000978
Anticholinergic Agents
D018680
Aza Compounds
D001372
Central Nervous System Agents
D002491
Cholinergic Agents
D018678
Cytochrome P-450 CYP2D6 Substrates

Cytochrome P-450 Substrates

Dopamine Agents
D015259
Dopamine Uptake Inhibitors
D018765
Drugs that are Mainly Renally Excreted

Ethers of Tropine or Tropine Derivatives

Histamine Antagonists
D006633
Histamine H1 Antagonists
D006634
Histamine Receptor Antagonists

Membrane Transport Modulators
D049990
Muscarinic Antagonists
D018727
Nervous System
D009420
Neurotransmitter Agents
D018377
Neurotransmitter Uptake Inhibitors
D014179
Peripheral Nervous System Agents
D018373
Potential QTc-Prolonging Agents

QTc Prolonging Agents

Tropanes
D014326

盐类

DBSALT000894Benzatropine mesylateWMJ8TL7510132-17-2CPFJLLXFNPCTDW-BWSPSPBFSA-N403.54403.181729592

蛋白质结合

About 95% of the administered dose of benztropine is found bound to plasma proteins.[T445]

清除

Extensive pharmacodynamic or pharmacokinetic studies have not been performed.

同义词

language:english; code:; name;3-alpha-(diphenylmethoxy)tropane
language:english; code:; name;3endo-benzhydryloxytropane
language:english; code:; name;3α-(diphenylmethoxy)-1αH,5αH-tropane
language:english; code:; name;3α-(diphenylmethoxy)tropane
language:english; code:; name;3α-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane
language:spanish; code:inn; name;Benzatropina
language:english; code:inn; name;Benzatropine
language:latin; code:inn; name;Benzatropinum
language:english; code:; name;benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether
language:english; code:; name;Benztropine
language:english; code:; name;Tropine benzohydryl ether

国际品牌

Apo-BenztropineApotexCogentinolAstra (Germany, discontinued)PMS BenztropinePharmascience

配送量

Benztropine is expected to present a large volume of distribution between 12-30 L/kg.[A175126]

产品

name:Bensylate Tab 2mg
labeller:Icn Pharmaceuticals
ndc-id:
ndc-product-code:
dpd-id:00428086
ema-product-code:
ema-ma-number:
started-marketing-on:1978-12-31
ended-marketing-on:2005-04-26
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Benztropine
labeller:Contract Pharmacy Services-PA
ndc-id:
ndc-product-code:67046-207
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-04-13
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine 2 Tab 2mg
labeller:Pro Doc Limitee
ndc-id:
ndc-product-code:
dpd-id:00563862
ema-product-code:
ema-ma-number:
started-marketing-on:1982-12-31
ended-marketing-on:2009-07-23
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Benztropine mesylate
labeller:Actavis Totowa LLC
ndc-id:
ndc-product-code:52152-318
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-07-30
ended-marketing-on:2010-07-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040699
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine mesylate
labeller:Actavis Totowa LLC
ndc-id:
ndc-product-code:52152-319
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-07-30
ended-marketing-on:2010-07-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040705
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine mesylate
labeller:Actavis Totowa LLC
ndc-id:
ndc-product-code:52152-320
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2008-02-01
ended-marketing-on:2008-08-20
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040706
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:State of Florida DOH Central Pharmacy
ndc-id:
ndc-product-code:53808-0210
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-07-01
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA072265
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:State of Florida DOH Central Pharmacy
ndc-id:
ndc-product-code:53808-0211
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-07-01
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA089059
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:State of Florida DOH Central Pharmacy
ndc-id:
ndc-product-code:53808-0904
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-07-01
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Contract Pharmacy Services Pa
ndc-id:
ndc-product-code:67046-042
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-06-28
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Contract Pharmacy Services Pa
ndc-id:
ndc-product-code:67046-043
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-06-28
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Goldline Laboratories, Inc.
ndc-id:
ndc-product-code:0182-1299
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-11-23
ended-marketing-on:2010-11-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA088877
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Goldline Laboratories, Inc.
ndc-id:
ndc-product-code:0182-1700
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-11-23
ended-marketing-on:2010-11-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA088894
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Goldline Laboratories, Inc.
ndc-id:
ndc-product-code:0182-1701
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-11-23
ended-marketing-on:2010-11-30
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA088895
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Rebel Distributors
ndc-id:
ndc-product-code:21695-286
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA072266
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Dispensing Solutions, Inc.
ndc-id:
ndc-product-code:66336-776
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-2301
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2008-06-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA072265
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Physicians Total Care, Inc.
ndc-id:
ndc-product-code:54868-2292
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2008-06-30
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA072266
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:49884-164
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-09-04
ended-marketing-on:2009-08-20
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA088877
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:49884-165
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-09-04
ended-marketing-on:2009-08-20
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA088894
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:49884-166
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-09-04
ended-marketing-on:2009-08-20
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA088895
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine mesylate
labeller:Hikma Farmaceutica
ndc-id:
ndc-product-code:62778-095
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-09-01
ended-marketing-on:2009-09-01
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:ANDA090287
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Camber Pharmaceuticals
ndc-id:
ndc-product-code:31722-218
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-08-01
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Camber Pharmaceuticals
ndc-id:
ndc-product-code:31722-219
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-08-01
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Camber Pharmaceuticals
ndc-id:
ndc-product-code:31722-220
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-08-01
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Mylan Institutional
ndc-id:
ndc-product-code:51079-404
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-10-05
ended-marketing-on:2012-06-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040738
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Mylan Institutional
ndc-id:
ndc-product-code:51079-406
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-30
ended-marketing-on:2012-09-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Mylan Institutional
ndc-id:
ndc-product-code:51079-407
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-10-16
ended-marketing-on:2011-10-31
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Ncs Health Care Of Ky, Inc Dba Vangard Labs
ndc-id:
ndc-product-code:0615-2547
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-28
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA089058
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Ncs Health Care Of Ky, Inc Dba Vangard Labs
ndc-id:
ndc-product-code:0615-2548
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-28
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA089059
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Ncs Health Care Of Ky, Inc Dba Vangard Labs
ndc-id:
ndc-product-code:0615-2549
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-28
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA089060
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:TYA Pharmaceuticals
ndc-id:
ndc-product-code:64725-0012
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-08-08
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:NDA012015
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:TYA Pharmaceuticals
ndc-id:
ndc-product-code:64725-2434
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:TYA Pharmaceuticals
ndc-id:
ndc-product-code:64725-2435
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-5757
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-28
ended-marketing-on:2012-10-31
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA089058
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-5758
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-28
ended-marketing-on:2012-10-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA089059
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Excellium Pharmaceutical, Inc.
ndc-id:
ndc-product-code:64125-136
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-12-01
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Excellium Pharmaceutical, Inc.
ndc-id:
ndc-product-code:64125-137
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-12-01
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Excellium Pharmaceutical, Inc.
ndc-id:
ndc-product-code:64125-138
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-12-01
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:State of Florida DOH Central Pharmacy
ndc-id:
ndc-product-code:53808-1014
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-11-01
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:State of Florida DOH Central Pharmacy
ndc-id:
ndc-product-code:53808-1020
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-11-01
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:State of Florida DOH Central Pharmacy
ndc-id:
ndc-product-code:53808-1015
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-11-01
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:State of Florida DOH Central Pharmacy
ndc-id:
ndc-product-code:53808-0826
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-01-01
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:State of Florida DOH Central Pharmacy
ndc-id:
ndc-product-code:53808-0825
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-01-01
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Aphena Pharma Solutions Tennessee, Inc.
ndc-id:
ndc-product-code:43353-913
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040738
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Aphena Pharma Solutions Tennessee, Inc.
ndc-id:
ndc-product-code:43353-796
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Ncs Health Care Of Ky, Inc Dba Vangard Labs
ndc-id:
ndc-product-code:0615-7676
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-12-12
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Ncs Health Care Of Ky, Inc Dba Vangard Labs
ndc-id:
ndc-product-code:0615-7677
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-12-12
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Ncs Health Care Of Ky, Inc Dba Vangard Labs
ndc-id:
ndc-product-code:0615-7675
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-12-12
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Rising Pharmaceuticals
ndc-id:
ndc-product-code:64980-111
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2010-04-21
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA072264
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Rising Pharmaceuticals
ndc-id:
ndc-product-code:64980-112
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2010-04-21
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA072265
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Rising Pharmaceuticals
ndc-id:
ndc-product-code:64980-113
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2010-04-21
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA072266
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:24236-015
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-09-06
ended-marketing-on:2011-10-20
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:false
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-700
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-04-11
ended-marketing-on:2015-01-16
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-126
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-09
ended-marketing-on:2011-12-10
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA072264
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-585
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-09-21
ended-marketing-on:2015-07-11
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-656
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-01-17
ended-marketing-on:2015-07-21
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040738
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Pliva, Inc.
ndc-id:
ndc-product-code:50111-393
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1990-09-30
ended-marketing-on:2017-02-28
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA089058
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Pliva, Inc.
ndc-id:
ndc-product-code:50111-394
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1990-09-30
ended-marketing-on:2016-08-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA089059
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Pliva, Inc.
ndc-id:
ndc-product-code:50111-395
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1990-09-30
ended-marketing-on:2016-12-31
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA089060
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:24236-705
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-09
ended-marketing-on:2011-12-09
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA072266
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-519
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-08-16
ended-marketing-on:2012-08-16
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA072264
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:52125-869
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-03-11
ended-marketing-on:2015-03-11
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA089059
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-231
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-03-14
ended-marketing-on:2012-04-09
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA072266
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-664
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-01-12
ended-marketing-on:2012-03-07
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA072265
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-461
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-12-16
ended-marketing-on:2011-12-17
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA072265
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:61786-352
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-06-19
ended-marketing-on:2017-07-25
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:49349-673
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-03-10
ended-marketing-on:2016-11-28
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Core Pharma, Llc
ndc-id:
ndc-product-code:64720-143
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2012-09-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA072264
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Core Pharma, Llc
ndc-id:
ndc-product-code:64720-144
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2013-08-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA072265
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Core Pharma, Llc
ndc-id:
ndc-product-code:64720-145
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2013-03-31
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA072266
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Aphena Pharma Solutions - Tennnessee, LLC
ndc-id:
ndc-product-code:43353-707
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Aphena Pharma Solutions - Tennnessee, LLC
ndc-id:
ndc-product-code:43353-580
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Pd Rx Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:43063-267
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-02-28
ended-marketing-on:2017-07-11
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA089059
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Clinical Solutions Wholsesale
ndc-id:
ndc-product-code:58118-2433
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2017-12-23
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040738
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Clinical Solutions Wholsesale
ndc-id:
ndc-product-code:58118-2434
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2017-10-15
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Clinical Solutions Wholsesale
ndc-id:
ndc-product-code:58118-2435
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2018-07-08
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:61786-113
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-12-15
ended-marketing-on:2017-03-06
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:61786-414
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-09-17
ended-marketing-on:2016-09-17
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:61786-038
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-09-23
ended-marketing-on:2017-02-02
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Remedy Repack
ndc-id:
ndc-product-code:61786-013
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-08-28
ended-marketing-on:2017-08-03
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:ANI Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:62559-570
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-10-25
ended-marketing-on:2016-10-26
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:ANI Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:62559-571
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-10-25
ended-marketing-on:2016-10-26
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:ANI Pharmaceuticals, Inc.
ndc-id:
ndc-product-code:62559-572
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-10-25
ended-marketing-on:2016-10-26
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-2792
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040738
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Mc Kesson Contract Packaging
ndc-id:
ndc-product-code:76237-274
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-02-21
ended-marketing-on:2017-09-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Mc Kesson Contract Packaging
ndc-id:
ndc-product-code:76237-275
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-12-12
ended-marketing-on:2017-09-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-5096
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-10-16
ended-marketing-on:2012-09-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-2695
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2017-07-31
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:0603-2437
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:0603-2438
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Par Pharmaceutical
ndc-id:
ndc-product-code:0603-2439
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Zydus Pharmaceuticals USA Inc.
ndc-id:
ndc-product-code:68382-860
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-12-30
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:ANDA091525
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-1347
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2012-08-31
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA072264
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-0696
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2002-08-13
ended-marketing-on:2013-02-28
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA072265
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Mc Kesson Contract Packaging
ndc-id:
ndc-product-code:76237-120
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-12-08
ended-marketing-on:2017-09-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA089059
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major
ndc-id:
ndc-product-code:0904-1055
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-02-23
ended-marketing-on:2012-09-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA072264
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major
ndc-id:
ndc-product-code:0904-1056
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-02-16
ended-marketing-on:2012-03-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA072265
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major
ndc-id:
ndc-product-code:0904-1057
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2006-02-16
ended-marketing-on:2012-03-31
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA072266
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Upsher-Smith Laboratories, LLC
ndc-id:
ndc-product-code:0832-1080
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-12-12
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Upsher-Smith Laboratories, LLC
ndc-id:
ndc-product-code:0832-1081
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-12-12
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Upsher-Smith Laboratories, LLC
ndc-id:
ndc-product-code:0832-1082
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-12-12
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:61786-008
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-08-13
ended-marketing-on:2018-10-11
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:American Health Packaging
ndc-id:
ndc-product-code:68084-388
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-18
ended-marketing-on:2018-10-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:American Health Packaging
ndc-id:
ndc-product-code:68084-389
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-18
ended-marketing-on:2018-10-31
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:American Health Packaging
ndc-id:
ndc-product-code:68084-381
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-11-04
ended-marketing-on:2019-09-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Qualitest Pharmaceuticals
ndc-id:
ndc-product-code:0603-2433
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2019-09-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040738
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Qualitest Pharmaceuticals
ndc-id:
ndc-product-code:0603-2434
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2019-09-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Qualitest Pharmaceuticals
ndc-id:
ndc-product-code:0603-2435
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2019-09-30
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:West-Ward Pharmaceuticals Corp
ndc-id:
ndc-product-code:0143-9729
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-09-01
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:ANDA090287
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Leading Pharma, Llc
ndc-id:
ndc-product-code:69315-136
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-28
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Leading Pharma, Llc
ndc-id:
ndc-product-code:69315-137
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-28
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Leading Pharma, Llc
ndc-id:
ndc-product-code:69315-138
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-28
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1447
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-10-01
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-4082
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Bayshore Pharmaceuticals Llc (Nj)
ndc-id:
ndc-product-code:76385-103
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-31
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Bayshore Pharmaceuticals Llc (Nj)
ndc-id:
ndc-product-code:76385-104
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-31
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Bayshore Pharmaceuticals Llc (Nj)
ndc-id:
ndc-product-code:76385-105
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-31
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Marlex Pharmaceuticals Inc
ndc-id:
ndc-product-code:10135-606
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-12-15
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Marlex Pharmaceuticals Inc
ndc-id:
ndc-product-code:10135-607
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-12-15
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Marlex Pharmaceuticals Inc
ndc-id:
ndc-product-code:10135-608
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-12-15
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:NCS HealthCare of KY, Inc dba Vangard Labs
ndc-id:
ndc-product-code:0615-8210
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:NCS HealthCare of KY, Inc dba Vangard Labs
ndc-id:
ndc-product-code:0615-8211
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Clinical Solutions Wholesale, LLC
ndc-id:
ndc-product-code:58118-0043
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-31
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major Pharmaceuticals
ndc-id:
ndc-product-code:0904-6788
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major Pharmaceuticals
ndc-id:
ndc-product-code:0904-6790
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major Pharmaceuticals
ndc-id:
ndc-product-code:0904-6789
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1470
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-10-05
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1490
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-10-06
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:American Health Packaging
ndc-id:
ndc-product-code:60687-356
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-08-31
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:American Health Packaging
ndc-id:
ndc-product-code:60687-368
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-04-03
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:American Health Packaging
ndc-id:
ndc-product-code:60687-379
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-04-04
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:NCS HealthCare of KY, Inc dba Vangard Labs
ndc-id:
ndc-product-code:0615-8088
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-28
ended-marketing-on:2020-01-31
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:NCS HealthCare of KY, Inc dba Vangard Labs
ndc-id:
ndc-product-code:0615-8089
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-28
ended-marketing-on:2020-01-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Proficient Rx LP
ndc-id:
ndc-product-code:63187-840
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-28
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Akorn, Inc.
ndc-id:
ndc-product-code:17478-012
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-08-08
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:NDA012015
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-3883
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-31
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Direct Rx
ndc-id:
ndc-product-code:61919-128
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-01
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:71335-0665
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-31
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-3882
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-01-31
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Fresenius Kabi USA, LLC
ndc-id:
ndc-product-code:63323-970
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-05-31
ended-marketing-on:
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:ANDA090233
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-0577
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-06-19
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cipla USA Inc.
ndc-id:
ndc-product-code:69097-826
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-06-29
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cipla USA Inc.
ndc-id:
ndc-product-code:69097-827
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-06-29
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cipla USA Inc.
ndc-id:
ndc-product-code:69097-832
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-06-29
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-0578
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-06-19
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-0649
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-07-28
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-0720
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-08-31
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-2732
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-05-11
ended-marketing-on:
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-2677
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-04-08
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major Pharmaceuticals
ndc-id:
ndc-product-code:0904-6539
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2018-09-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA040738
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major Pharmaceuticals
ndc-id:
ndc-product-code:0904-6540
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2017-11-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Major Pharmaceuticals
ndc-id:
ndc-product-code:0904-6541
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2018-09-30
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:52125-073
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-07-16
ended-marketing-on:2017-06-16
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1056
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-03-12
ended-marketing-on:2020-05-11
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1709
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-12-04
ended-marketing-on:2020-05-28
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-3382
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:2019-06-30
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:61786-018
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-09-03
ended-marketing-on:2018-08-30
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:61786-708
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-05-19
ended-marketing-on:2017-10-12
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:52125-431
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-01-31
ended-marketing-on:2018-04-20
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:A-S Medication Solutions
ndc-id:
ndc-product-code:50090-3116
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:2019-07-18
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:49349-933
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-13
ended-marketing-on:2018-06-21
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:SUNRISE PHARMACEUTICAL, INC
ndc-id:
ndc-product-code:11534-167
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-07-15
ended-marketing-on:2018-05-31
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:SUNRISE PHARMACEUTICAL, INC
ndc-id:
ndc-product-code:11534-168
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-07-15
ended-marketing-on:2018-05-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:SUNRISE PHARMACEUTICAL, INC
ndc-id:
ndc-product-code:11534-169
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-07-15
ended-marketing-on:2018-05-31
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:52125-169
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-08-16
ended-marketing-on:2013-08-16
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:63629-4302
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2013-10-01
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:63629-4121
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2007-08-27
ended-marketing-on:2015-05-30
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1688
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-11-23
ended-marketing-on:2020-05-28
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1455
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-10-02
ended-marketing-on:2020-05-21
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:bryant ranch prepack
ndc-id:
ndc-product-code:71335-0382
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-28
ended-marketing-on:2019-07-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1691
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-11-26
ended-marketing-on:2020-05-28
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Clinical Solutions Wholesale, LLC
ndc-id:
ndc-product-code:58118-0136
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-09-12
ended-marketing-on:2018-10-30
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Clinical Solutions Wholesale, LLC
ndc-id:
ndc-product-code:58118-0138
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-08-31
ended-marketing-on:2018-10-30
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090168
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:52125-330
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-27
ended-marketing-on:2018-01-09
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040103
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-2094
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2010-01-14
ended-marketing-on:2018-10-31
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1005
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-02-07
ended-marketing-on:2020-05-07
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-1217
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2018-05-17
ended-marketing-on:2020-03-27
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-0881
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-11-30
ended-marketing-on:2020-05-07
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-0129
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-01-17
ended-marketing-on:2018-01-19
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA040715
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:AMERICAN REGENT, INC.
ndc-id:
ndc-product-code:0517-0785
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-02-04
ended-marketing-on:2012-10-31
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:ANDA091152
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:REMEDYREPACK INC.
ndc-id:
ndc-product-code:70518-0132
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-01-17
ended-marketing-on:2018-03-03
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA040742
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:AvPAK
ndc-id:
ndc-product-code:50268-115
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-03-25
ended-marketing-on:2018-09-05
dosage-form:Tablet
strength:0.5 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:AvPAK
ndc-id:
ndc-product-code:50268-116
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-03-25
ended-marketing-on:2018-09-05
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:AvPAK
ndc-id:
ndc-product-code:50268-117
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-03-25
ended-marketing-on:2018-09-05
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA090294
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Cardinal Health
ndc-id:
ndc-product-code:55154-8095
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:1 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Navinta Llc
ndc-id:
ndc-product-code:68475-512
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-11-24
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:ANDA091525
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:Wintac Limited
ndc-id:
ndc-product-code:10858-011
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2020-11-26
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:ANDA091525
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate
labeller:NCS HealthCare of KY, Inc dba Vangard Labs
ndc-id:
ndc-product-code:0615-8352
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-05-15
ended-marketing-on:
dosage-form:Tablet
strength:2 mg/1
route:Oral
fda-application-number:ANDA204713
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate Injection, USP
labeller:Nexus Pharmaceuticals Inc
ndc-id:
ndc-product-code:14789-300
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-07-29
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Parenteral
fda-application-number:ANDA090233
generic:true
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Benztropine Mesylate Injection, USP
labeller:Sabex Inc
ndc-id:
ndc-product-code:
dpd-id:02243121
ema-product-code:
ema-ma-number:
started-marketing-on:
ended-marketing-on:
dosage-form:Liquid
strength:1 mg
route:Intramuscular; Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Benztropine Omega
labeller:Omega Laboratories Ltd
ndc-id:
ndc-product-code:
dpd-id:02238903
ema-product-code:
ema-ma-number:
started-marketing-on:1999-05-28
ended-marketing-on:
dosage-form:Liquid
strength:
route:Intramuscular; Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Cogentin
labeller:Lundbeck Inc.
ndc-id:
ndc-product-code:67386-611
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1959-08-05
ended-marketing-on:2011-12-22
dosage-form:Injection, solution
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:NDA012015
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Cogentin
labeller:Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)
ndc-id:
ndc-product-code:76478-611
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1959-08-05
ended-marketing-on:
dosage-form:Injection
strength:1 mg/1mL
route:Intramuscular; Intravenous
fda-application-number:NDA012015
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Cogentin Inj 1mg/ml
labeller:Merck Frosst Canada & Cie, Merck Frosst Canada & Co.
ndc-id:
ndc-product-code:
dpd-id:00016128
ema-product-code:
ema-ma-number:
started-marketing-on:1959-12-31
ended-marketing-on:2004-07-29
dosage-form:Solution
strength:
route:Intramuscular; Intravenous
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Cogentin Tab 2mg
labeller:Merck Frosst Canada & Cie, Merck Frosst Canada & Co.
ndc-id:
ndc-product-code:
dpd-id:00016357
ema-product-code:
ema-ma-number:
started-marketing-on:1954-12-31
ended-marketing-on:2003-01-29
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:false
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Dom-benztropine
labeller:Dominion Pharmacal
ndc-id:
ndc-product-code:
dpd-id:02241791
ema-product-code:
ema-ma-number:
started-marketing-on:
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Pdp-benztropine
labeller:Pendopharm Division Of Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:00426857
ema-product-code:
ema-ma-number:
started-marketing-on:1978-12-31
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Pdp-benztropine
labeller:Pendopharm Division Of Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:00706531
ema-product-code:
ema-ma-number:
started-marketing-on:1987-12-31
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Pdp-benztropine
labeller:Pendopharm Division Of Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:02219727
ema-product-code:
ema-ma-number:
started-marketing-on:1997-08-20
ended-marketing-on:2019-10-16
dosage-form:Solution
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:PMS-benztropine 2mg/tab
labeller:Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:00587265
ema-product-code:
ema-ma-number:
started-marketing-on:1984-12-31
ended-marketing-on:
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:PMS-benztropine Tab 0.5mg
labeller:Pharmascience Inc
ndc-id:
ndc-product-code:
dpd-id:00885452
ema-product-code:
ema-ma-number:
started-marketing-on:1990-12-31
ended-marketing-on:2014-09-08
dosage-form:Tablet
strength:
route:Oral
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD
name:Vpi-benztropine
labeller:Vpi Pharmaceuticals Inc
ndc-id:
ndc-product-code:
dpd-id:02486822
ema-product-code:
ema-ma-number:
started-marketing-on:2019-12-03
ended-marketing-on:
dosage-form:Solution
strength:
route:Intramuscular; Intravenous
fda-application-number:
generic:true
over-the-counter:false
approved:true
country:Canada
source:DPD

混合物

name:Benztropine Mesylate Injection, USP
ingredients:Benzatropine
name:Benztropine mesylate
ingredients:Benzatropine
name:Benztropine mesylate
ingredients:Benzatropine
name:Benztropine mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Cogentin
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Cogentin
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Mesylate
ingredients:Benzatropine
name:Benztropine Omega
ingredients:Benzatropine
name:PMS-benztropine Tab 0.5mg
ingredients:Benzatropine
name:Cogentin Inj 1mg/ml
ingredients:Benzatropine
name:Cogentin Tab 2mg
ingredients:Benzatropine
name:Bensylate Tab 2mg
ingredients:Benzatropine
name:Benztropine 2 Tab 2mg
ingredients:Benzatropine
name:Dom-benztropine
ingredients:Benzatropine
name:Benztropine Mesylate Injection, USP
ingredients:Benzatropine
name:Pdp-benztropine
ingredients:Benzatropine
name:Pdp-benztropine
ingredients:Benzatropine
name:Pdp-benztropine
ingredients:Benzatropine
name:PMS-benztropine 2mg/tab
ingredients:Benzatropine
name:Vpi-benztropine
ingredients:Benzatropine

包装者

name:Advanced Pharmaceutical Services Inc.
url:
name:Amerisource Health Services Corp.
url:http://www.amerisourcebergen.com
name:Amneal Pharmaceuticals
url:http://www.amneal.com
name:AQ Pharmaceuticals Inc.
url:http://www.aqpharmaceuticals.com
name:Cardinal Health
url:http://www.cardinal.com
name:Comprehensive Consultant Services Inc.
url:
name:Corepharma LLC
url:http://www.corepharma.com
name:Coupler Enterprises Inc.
url:
name:Dept Health Central Pharmacy
url:
name:Direct Dispensing Inc.
url:
name:Dispensing Solutions
url:http://www.drxdispensing.com
name:Goldline Laboratories Inc.
url:
name:Heartland Repack Services LLC
url:
name:Hikma Pharmaceuticals
url:http://www.hikma.com
name:Ivax Pharmaceuticals
url:
name:Liberty Pharmaceuticals
url:
name:Lundbeck Inc.
url:http://www.lundbeckinc.com
name:Major Pharmaceuticals
url:http://www.majorpharmaceuticals.com
name:Medisca Inc.
url:http://www.medisca.com
name:Merck & Co.
url:http://www.merck.com
name:Murfreesboro Pharmaceutical Nursing Supply
url:http://www.unitdosesupply.com
name:Neuman Distributors Inc.
url:
name:Nexus Pharmaceuticals
url:http://www.nexuspharma.net
name:Nucare Pharmaceuticals Inc.
url:http://www.nucarerx.com
name:PCA LLC
url:
name:Pharmaceutical Packaging Center
url:
name:Pharmedix
url:http://www.pharmedixrx.com
name:Physicians Total Care Inc.
url:http://www.physicianstotalcare.com
name:Pliva Inc.
url:http://www.pliva.com
name:Prepackage Specialists
url:
name:Prepak Systems Inc.
url:http://www.prepaksys.com
name:Qualitest
url:http://www.worldoftest.com
name:Rebel Distributors Corp.
url:http://www.rebelrx.com
name:Remedy Repack
url:http://www.remedyrepack.com
name:Rising Pharmaceuticals
url:http://www.risingpharma.com
name:Sandhills Packaging Inc.
url:http://www.sandhillspackaging.com
name:Schein Pharmaceutical Inc.
url:
name:Southwood Pharmaceuticals
url:http://www.southwoodhealthcare.com
name:Tya Pharmaceuticals
url:
name:UDL Laboratories
url:http://www.udllabs.com
name:United Research Laboratories Inc.
url:http://www.urlpharma.com
name:USL Pharma Inc.
url:
name:Vangard Labs Inc.
url:
name:Vintage Pharmaceuticals Inc.
url:
name:West-Ward Pharmaceuticals
url:http://www.west-ward.com

生产者

generic:是; url:; name;Hikma farmaceutica (portugal) sa
generic:是; url:; name;Nexus pharmaceuticals inc
generic:是; url:; name;Pharmaforce inc
generic:否; url:; name;Lundbeck inc
generic:是; url:; name;Actavis totowa llc
generic:是; url:; name;Corepharma llc
generic:是; url:; name;Invagen pharmaceuticals inc
generic:是; url:; name;Lannett holdings inc
generic:是; url:; name;Mutual pharmaceutical co inc
generic:是; url:; name;Pliva inc
generic:是; url:; name;Quantum pharmics ltd
generic:是; url:; name;Usl pharma inc
generic:是; url:; name;Vintage pharmaceuticals llc
generic:否; url:; name;Merck and co inc

价格

Benztropine mesylate powder
26.38(单位：USD）
g
Benztropine 2 mg/2 ml vial
33.0(单位：USD）
ml
Benztropine 2 mg/2 ml ampule
37.5(单位：USD）
ml
Cogentin 2 mg/2 ml ampule
70.09(单位：USD）
ml
Pms-Benztropine 1 mg Tablet
0.02(单位：USD）
tablet
Pms-Benztropine 2 mg Tablet
0.05(单位：USD）
tablet
Apo-Benztropine 2 mg Tablet
0.06(单位：USD）
tablet
Benztropine Mesylate 2 mg tablet
0.26(单位：USD）
tablet
Benztropine Mesylate 0.5 mg tablet
0.27(单位：USD）
tablet
Benztropine Mesylate 1 mg tablet
0.27(单位：USD）
tablet
Benztropine mes 0.5 mg tablet
0.34(单位：USD）
tablet
Benztropine mes 1 mg tablet
0.38(单位：USD）
tablet
Benztropine mes 2 mg tablet
0.41(单位：USD）
tablet

受影响的生物体

Humans and other mammals

剂量

form:Injection
route:Intramuscular; Intravenous
strength:1 mg/1mL
form:Injection, solution
route:Intramuscular; Intravenous
strength:1 mg/1mL
form:Tablet
route:Oral
strength:0.5 mg/1
form:Tablet
route:Oral
strength:1 mg/1
form:Tablet
route:Oral
strength:2 mg/1
form:Injection
route:Parenteral
strength:1 mg/1mL
form:Liquid
route:Intramuscular; Intravenous
strength:1 mg
form:Liquid
route:Intramuscular; Intravenous
strength:
form:Solution
route:Intramuscular; Intravenous
strength:
form:Solution
route:Oral
strength:
form:Tablet
route:Oral
strength:
form:Injection, solution
route:Intramuscular; Intravenous
strength:2 mg/2ml

atc代码

Ethers of tropine or tropine derivatives
ANTICHOLINERGIC AGENTS
ANTI-PARKINSON DRUGS
NERVOUS SYSTEM

fda标签

//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00245.pdf?1550877431

化学品安全技术说明书

//s3-us-west-2.amazonaws.com/drugbank/msds/DB00245.pdf?1265922737

专利

食物相互作用

Avoid alcohol.Take with food. Food reduces irritation.

药物相互作用

DB08897
The risk or severity of adverse effects can be increased when Benzatropine is combined with Aclidinium.
DB06148
Mianserin may increase the anticholinergic activities of Benzatropine.
DB08893
The risk or severity of urinary retention can be increased when Benzatropine is combined with Mirabegron.
DB00761
The risk or severity of gastrointestinal ulceration can be increased when Benzatropine is combined with Potassium chloride.
DB01278
The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Benzatropine.
DB09527
The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Benzatropine.
DB01409
The risk or severity of adverse effects can be increased when Benzatropine is combined with Tiotropium.
DB00273
The risk or severity of hyperthermia and oligohydrosis can be increased when Benzatropine is combined with Topiramate.
DB09076
The risk or severity of adverse effects can be increased when Benzatropine is combined with Umeclidinium.
DB08824
Benzatropine may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.
DB00422
The risk or severity of adverse effects can be increased when Methylphenidate is combined with Benzatropine.
DB06701
The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Benzatropine.
DB00895
Benzatropine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
DB06698
The therapeutic efficacy of Betahistine can be decreased when used in combination with Benzatropine.
DB00070
The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Benzatropine.
DB06205
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Benzatropine.
DB14740
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Benzatropine.
DB00986
The risk or severity of adverse effects can be increased when Benzatropine is combined with Glycopyrronium.
DB00083
The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum toxin type A.
DB00040
Benzatropine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00042
The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum Toxin Type B.
DB09272
The risk or severity of constipation can be increased when Benzatropine is combined with Eluxadoline.
DB09290
The risk or severity of constipation can be increased when Benzatropine is combined with Ramosetron.
DB00182
Amphetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB00191
Phentermine may decrease the sedative and stimulatory activities of Benzatropine.
DB00852
Pseudoephedrine may decrease the sedative and stimulatory activities of Benzatropine.
DB00865
Benzphetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB00937
Diethylpropion may decrease the sedative and stimulatory activities of Benzatropine.
DB01255
Lisdexamfetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB01365
Mephentermine may decrease the sedative and stimulatory activities of Benzatropine.
DB01442
MMDA may decrease the sedative and stimulatory activities of Benzatropine.
DB01454
Midomafetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB01467
2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB01484
4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB01509
Tenamfetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB01556
Chlorphentermine may decrease the sedative and stimulatory activities of Benzatropine.
DB01566
Methylenedioxyethamphetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB01576
Dextroamphetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB01577
Metamfetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB09480
Iofetamine I-123 may decrease the sedative and stimulatory activities of Benzatropine.
DB12080
Ritobegron may decrease the sedative and stimulatory activities of Benzatropine.
DB13108
Mephedrone may decrease the sedative and stimulatory activities of Benzatropine.
DB13624
Methoxyphenamine may decrease the sedative and stimulatory activities of Benzatropine.
DB13703
Gepefrine may decrease the sedative and stimulatory activities of Benzatropine.
DB13940
2,5-Dimethoxy-4-ethylthioamphetamine may decrease the sedative and stimulatory activities of Benzatropine.
DB00704
The risk or severity of adverse effects can be increased when Benzatropine is combined with Naltrexone.
DB01459
The risk or severity of adverse effects can be increased when Benzatropine is combined with Bezitramide.
DB00193
The risk or severity of adverse effects can be increased when Tramadol is combined with Benzatropine.
DB00295
The risk or severity of adverse effects can be increased when Morphine is combined with Benzatropine.
DB00327
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Benzatropine.
DB00497
The risk or severity of adverse effects can be increased when Oxycodone is combined with Benzatropine.
DB00611
The risk or severity of adverse effects can be increased when Butorphanol is combined with Benzatropine.
DB00652
The risk or severity of adverse effects can be increased when Pentazocine is combined with Benzatropine.
DB00708
The risk or severity of adverse effects can be increased when Sufentanil is combined with Benzatropine.
DB00802
The risk or severity of adverse effects can be increased when Alfentanil is combined with Benzatropine.
DB00844
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzatropine.
DB00854
The risk or severity of adverse effects can be increased when Levorphanol is combined with Benzatropine.
DB00899
The risk or severity of adverse effects can be increased when Remifentanil is combined with Benzatropine.
DB00921
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Benzatropine.
DB00956
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Benzatropine.
DB01081
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Benzatropine.
DB01192
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Benzatropine.
DB01209
The risk or severity of adverse effects can be increased when Dezocine is combined with Benzatropine.
DB01433
The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Benzatropine.
DB01450
The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Benzatropine.
DB01452
The risk or severity of adverse effects can be increased when Diamorphine is combined with Benzatropine.
DB01466
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Benzatropine.
DB01497
The risk or severity of adverse effects can be increased when Etorphine is combined with Benzatropine.
DB01529
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Benzatropine.
DB01531
The risk or severity of adverse effects can be increased when Desomorphine is combined with Benzatropine.
DB01535
The risk or severity of adverse effects can be increased when Carfentanil is combined with Benzatropine.
DB01551
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Benzatropine.
DB01555
The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Benzatropine.
DB01565
The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Benzatropine.
DB06738
The risk or severity of adverse effects can be increased when Ketobemidone is combined with Benzatropine.
DB08861
The risk or severity of adverse effects can be increased when DPDPE is combined with Benzatropine.
DB09174
The risk or severity of adverse effects can be increased when Lofentanil is combined with Benzatropine.
DB11130
The risk or severity of adverse effects can be increased when Opium is combined with Benzatropine.
DB11609
The risk or severity of adverse effects can be increased when Normethadone is combined with Benzatropine.
DB12492
The risk or severity of adverse effects can be increased when Piritramide is combined with Benzatropine.
DB13160
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Benzatropine.
DB13454
The risk or severity of adverse effects can be increased when Nicomorphine is combined with Benzatropine.
DB13478
The risk or severity of adverse effects can be increased when Meptazinol is combined with Benzatropine.
DB13605
The risk or severity of adverse effects can be increased when Phenoperidine is combined with Benzatropine.
DB13606
The risk or severity of adverse effects can be increased when Phenazocine is combined with Benzatropine.
DB13787
The risk or severity of adverse effects can be increased when Tilidine is combined with Benzatropine.
DB15360
The risk or severity of adverse effects can be increased when Carfentanil, C-11 is combined with Benzatropine.
DB01227
The risk or severity of adverse effects can be increased when Benzatropine is combined with Levacetylmethadol.
DB00318
The risk or severity of adverse effects can be increased when Benzatropine is combined with Codeine.
DB00813
The risk or severity of adverse effects can be increased when Benzatropine is combined with Fentanyl.
DB00333
The risk or severity of adverse effects can be increased when Methadone is combined with Benzatropine.
DB00647
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Benzatropine.
DB06204
The risk or severity of adverse effects can be increased when Tapentadol is combined with Benzatropine.
DB00454
The risk or severity of adverse effects can be increased when Benzatropine is combined with Meperidine.
DB15465
The risk or severity of adverse effects can be increased when Benzatropine is combined with Benzhydrocodone.
DB00209
The risk or severity of adverse effects can be increased when Trospium is combined with Benzatropine.
DB00219
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Benzatropine.
DB00340
The risk or severity of adverse effects can be increased when Benzatropine is combined with Metixene.
DB00376
The risk or severity of adverse effects can be increased when Benzatropine is combined with Trihexyphenidyl.
DB00383
The risk or severity of adverse effects can be increased when Benzatropine is combined with Oxyphencyclimine.
DB00387
The risk or severity of adverse effects can be increased when Benzatropine is combined with Procyclidine.
DB00462
The risk or severity of adverse effects can be increased when Benzatropine is combined with Methscopolamine bromide.
DB00505
The risk or severity of adverse effects can be increased when Benzatropine is combined with Tridihexethyl.
DB00517
The risk or severity of adverse effects can be increased when Benzatropine is combined with Anisotropine methylbromide.
DB00670
The risk or severity of adverse effects can be increased when Benzatropine is combined with Pirenzepine.
DB00725
The risk or severity of adverse effects can be increased when Benzatropine is combined with Homatropine methylbromide.
DB00767
The risk or severity of adverse effects can be increased when Benzatropine is combined with Benzquinamide.
DB00809
The risk or severity of adverse effects can be increased when Benzatropine is combined with Tropicamide.
DB00940
The risk or severity of adverse effects can be increased when Benzatropine is combined with Methantheline.
DB00942
The risk or severity of adverse effects can be increased when Benzatropine is combined with Cycrimine.
DB00979
The risk or severity of adverse effects can be increased when Benzatropine is combined with Cyclopentolate.
DB01090
The risk or severity of adverse effects can be increased when Benzatropine is combined with Pentolinium.
DB01116
The risk or severity of adverse effects can be increased when Benzatropine is combined with Trimethaphan.
DB01161
The risk or severity of adverse effects can be increased when Benzatropine is combined with Chloroprocaine.
DB01231
The risk or severity of adverse effects can be increased when Benzatropine is combined with Diphenidol.
DB01288
The risk or severity of adverse effects can be increased when Benzatropine is combined with Fenoterol.
DB01496
The risk or severity of adverse effects can be increased when Benzatropine is combined with Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione.
DB01625
The risk or severity of adverse effects can be increased when Benzatropine is combined with Isopropamide.
DB04843
The risk or severity of adverse effects can be increased when Benzatropine is combined with Mepenzolate.
DB06787
The risk or severity of adverse effects can be increased when Benzatropine is combined with Hexocyclium.
DB08801
The risk or severity of adverse effects can be increased when Benzatropine is combined with Dimetindene.
DB08838
The risk or severity of adverse effects can be increased when Benzatropine is combined with Agmatine.
DB08997
The risk or severity of adverse effects can be increased when Benzatropine is combined with Dexetimide.
DB09007
The risk or severity of adverse effects can be increased when Benzatropine is combined with Chlorphenoxamine.
DB09300
The risk or severity of adverse effects can be increased when Benzatropine is combined with Butylscopolamine.
DB11181
The risk or severity of adverse effects can be increased when Benzatropine is combined with Homatropine.
DB11235
The risk or severity of adverse effects can be increased when Benzatropine is combined with Thonzylamine.
DB11315
The risk or severity of adverse effects can be increased when Benzatropine is combined with Methscopolamine.
DB12086
The risk or severity of adverse effects can be increased when Benzatropine is combined with Oxitropium.
DB12526
The risk or severity of adverse effects can be increased when Benzatropine is combined with Batefenterol.
DB12554
The risk or severity of adverse effects can be increased when Benzatropine is combined with Mebeverine.
DB13252
The risk or severity of adverse effects can be increased when Benzatropine is combined with Tropatepine.
DB13254
The risk or severity of adverse effects can be increased when Benzatropine is combined with Prifinium.
DB13351
The risk or severity of adverse effects can be increased when Benzatropine is combined with Piperidolate.
DB13369
The risk or severity of adverse effects can be increased when Benzatropine is combined with Benzilone.
DB13380
The risk or severity of adverse effects can be increased when Benzatropine is combined with Difemerine.
DB13413
The risk or severity of adverse effects can be increased when Benzatropine is combined with Phenglutarimide.
DB13448
The risk or severity of adverse effects can be increased when Benzatropine is combined with Mazaticol.
DB13468
The risk or severity of adverse effects can be increased when Benzatropine is combined with Etybenzatropine.
DB13507
The risk or severity of adverse effects can be increased when Benzatropine is combined with Poldine.
DB13542
The risk or severity of adverse effects can be increased when Benzatropine is combined with Bevonium.
DB13581
The risk or severity of adverse effects can be increased when Benzatropine is combined with Rociverine.
DB13619
The risk or severity of adverse effects can be increased when Benzatropine is combined with Bornaprine.
DB13636
The risk or severity of adverse effects can be increased when Benzatropine is combined with Etanautine.
DB13666
The risk or severity of adverse effects can be increased when Benzatropine is combined with Tiemonium iodide.
DB13678
The risk or severity of adverse effects can be increased when Benzatropine is combined with Dihexyverine.
DB13695
The risk or severity of adverse effects can be increased when Benzatropine is combined with Penthienate.
DB13720
The risk or severity of adverse effects can be increased when Benzatropine is combined with Diphemanil.
DB13738
The risk or severity of adverse effects can be increased when Benzatropine is combined with Camylofin.
DB13759
The risk or severity of adverse effects can be increased when Benzatropine is combined with Fenpiverinium.
DB13769
The risk or severity of adverse effects can be increased when Benzatropine is combined with Emetonium iodide.
DB13844
The risk or severity of adverse effects can be increased when Benzatropine is combined with Pipenzolate.
DB13850
The risk or severity of adverse effects can be increased when Benzatropine is combined with Timepidium.
DB09271
The risk or severity of adverse effects can be increased when Benzatropine is combined with Cimetropium.
DB04888
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Bifeprunox.
DB05316
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Pimavanserin.
DB06016
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Cariprazine.
DB09128
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Brexpiprazole.
DB09226
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Brilaroxazine.
DB00332
The risk or severity of adverse effects can be increased when Benzatropine is combined with Ipratropium.
DB00470
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Dronabinol.
DB00486
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Nabilone.
DB05077
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with SLV319.
DB06155
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Rimonabant.
DB06624
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Taranabant.
DB09061
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Cannabidiol.
DB11903
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with GW842166.
DB12193
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Ajulemic acid.
DB12649
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Ibipinabant.
DB13070
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Surinabant.
DB13950
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with WIN 55212-2.
DB14011
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Nabiximols.
DB14043
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Palmidrol.
DB14737
The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Cannabinol.
DB00082
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Pegvisomant.
DB00382
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Tacrine.
DB00392
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Profenamine.
DB00527
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Cinchocaine.
DB00545
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Pyridostigmine.
DB00585
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Nizatidine.
DB00677
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Isoflurophate.
DB00711
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Diethylcarbamazine.
DB00888
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Mechlorethamine.
DB00944
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Demecarium.
DB00981
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Physostigmine.
DB00989
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Rivastigmine.
DB01010
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Edrophonium.
DB01043
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Memantine.
DB01122
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Ambenonium.
DB01381
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Ginkgo biloba.
DB01400
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Neostigmine.
DB01408
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Bambuterol.
DB02365
The therapeutic efficacy of Benzatropine can be decreased when used in combination with 1,10-Phenanthroline.
DB04572
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Thiotepa.
DB04864
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Huperzine A.
DB04892
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Phenserine.
DB05386
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Regramostim.
DB06692
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Aprotinin.
DB06756
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Glycine betaine.
DB06774
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Capsaicin.
DB11473
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Metrifonate.
DB12482
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Acotiamide.
DB13058
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Methanesulfonyl Fluoride.
DB13495
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Paraoxon.
DB13503
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Tyrothricin.
DB13668
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Ipidacrine.
DB13694
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Distigmine.
DB14031
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Tretamine.
DB15317
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Posiphen.
DB02845
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Methylphosphinic Acid.
DB00581
The therapeutic efficacy of Lactulose can be decreased when used in combination with Benzatropine.
DB01377
The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Benzatropine.
DB01378
The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Benzatropine.
DB01593
The therapeutic efficacy of Zinc can be decreased when used in combination with Benzatropine.
DB04816
The therapeutic efficacy of Dantron can be decreased when used in combination with Benzatropine.
DB04823
The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Benzatropine.
DB04824
The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Benzatropine.
DB07715
The therapeutic efficacy of Emodin can be decreased when used in combination with Benzatropine.
DB08890
The therapeutic efficacy of Linaclotide can be decreased when used in combination with Benzatropine.
DB09020
The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Benzatropine.
DB09287
The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Benzatropine.
DB09311
The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Benzatropine.
DB09413
The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Benzatropine.
DB09414
The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Benzatropine.
DB09449
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Benzatropine.
DB09462
The therapeutic efficacy of Glycerin can be decreased when used in combination with Benzatropine.
DB09484
The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Benzatropine.
DB11057
The therapeutic efficacy of Mineral oil can be decreased when used in combination with Benzatropine.
DB11059
The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Benzatropine.
DB11089
The therapeutic efficacy of Docusate can be decreased when used in combination with Benzatropine.
DB11097
The therapeutic efficacy of Plantago seed can be decreased when used in combination with Benzatropine.
DB11110
The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Benzatropine.
DB11113
The therapeutic efficacy of Castor oil can be decreased when used in combination with Benzatropine.
DB11189
The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Benzatropine.
DB11228
The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Benzatropine.
DB11365
The therapeutic efficacy of Sennosides can be decreased when used in combination with Benzatropine.
DB12942
The therapeutic efficacy of Lactitol can be decreased when used in combination with Benzatropine.
DB13170
The therapeutic efficacy of Plecanatide can be decreased when used in combination with Benzatropine.
DB13486
The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Benzatropine.
DB13526
The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Benzatropine.
DB13707
The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Benzatropine.
DB14232
The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Benzatropine.
DB14482
The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Benzatropine.
DB14502
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Benzatropine.
DB14503
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Benzatropine.
DB14504
The therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Benzatropine.
DB14513
The therapeutic efficacy of Magnesium can be decreased when used in combination with Benzatropine.
DB14585
The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Benzatropine.
DB14627
The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Benzatropine.
DB14684
The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Benzatropine.
DB14963
The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Benzatropine.
DB15477
The therapeutic efficacy of Alloin can be decreased when used in combination with Benzatropine.
DB15478
The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Benzatropine.
DB11622
The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Benzatropine.
DB14516
The therapeutic efficacy of Sodium cation can be decreased when used in combination with Benzatropine.
DB14546
The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Benzatropine.
DB00483
Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00721
Procaine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00805
Minaprine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00941
Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01199
Tubocurarine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01221
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01245
Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01337
Pancuronium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01338
Pipecuronium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00150
Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00181
Baclofen may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00186
Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00189
Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00202
Succinylcholine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00216
Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00228
Enflurane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00230
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00231
Temazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00234
Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00237
Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00241
Butalbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00247
Methysergide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00248
Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00268
Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00292
Etomidate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00306
Talbutal may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00312
Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00315
Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00320
Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00323
Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00347
Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00356
Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00366
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00370
Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00371
Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00395
Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00402
Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00404
Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00405
Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00416
Metocurine iodide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00418
Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00423
Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00425
Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00427
Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00434
Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00463
Metharbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00474
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00475
Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00494
Entacapone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00514
Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00546
Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00555
Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00565
Cisatracurium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00579
Mazindol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00588
Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00593
Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00599
Thiopental may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00601
Linezolid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00614
Furazolidone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00617
Paramethadione may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00628
Clorazepic acid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00645
Dyclonine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00660
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00662
Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00680
Moricizine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00683
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00690
Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00696
Ergotamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00697
Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00714
Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00728
Rocuronium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00732
Atracurium besylate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00737
Meclizine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00740
Riluzole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00747
Scopolamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00753
Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00754
Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00771
Clidinium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00776
Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00794
Primidone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00801
Halazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00818
Propofol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00819
Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00829
Diazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00832
Phensuximide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00835
Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00837
Progabide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00842
Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00849
Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00866
Alprenolol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00897
Triazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00898
Ethanol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00906
Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00909
Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00934
Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00949
Felbamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00952
Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00962
Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00969
Alosetron may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00972
Azelastine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00980
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00996
Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00998
Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01018
Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01028
Methoxyflurane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01037
Selegiline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01041
Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01049
Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01065
Melatonin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01068
Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01080
Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01106
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01107
Methyprylon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01121
Phenacemide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01135
Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01154
Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01159
Halothane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01168
Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01174
Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01176
Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01178
Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01189
Desflurane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01198
Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01200
Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01202
Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01215
Estazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01219
Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01226
Mivacurium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01236
Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01246
Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01247
Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01253
Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01323
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01336
Metocurine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01339
Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01351
Amobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01352
Aprobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01353
Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01354
Heptabarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01355
Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01440
gamma-Hydroxybutyric acid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01445
Bufotenine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01463
Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01472
4-Methoxyamphetamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01483
Barbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01488
Dimethyltryptamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01489
Camazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01495
Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01501
Difenoxin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01511
Delorazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01534
Chlorhexadol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01544
Flunitrazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01545
Ethyl loflazepate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01547
Drotebanol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01553
Cloxazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01558
Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01559
Clotiazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01560
Cathinone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01563
Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01567
Fludiazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01587
Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01588
Prazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01589
Quazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01594
Cinolazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01595
Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01616
Alverine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01626
Pargyline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01954
Rolipram may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB02207
7-Nitroindazole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB02234
S-Ethylisothiourea may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB02852
Domoic Acid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB02959
Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB03575
Phencyclidine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04017
Clorgiline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04165
Valpromide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04325
Phenethylamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04599
Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04819
Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04820
Nialamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04821
Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04827
Urethane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04829
Lysergic acid diethylamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04832
Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04833
Methaqualone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04834
Rapacuronium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04836
Amineptine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04841
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04872
Osanetant may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04885
Cilansetron may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04903
Pagoclone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04908
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04917
Renzapride may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB04953
Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05227
APD791 may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05232
Tetrodotoxin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05246
Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05541
Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05542
Naronapride may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05562
Naluzotan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05607
PRX-08066 may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05687
BL-1020 may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB05710
Gantacurium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06153
Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06201
Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06218
Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06264
Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06282
Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06283
Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06446
Dotarizine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06458
Remacemide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06470
Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06512
Deramciclane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06527
Tramiprosate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06529
Ocinaplon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06554
Gaboxadol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06579
Adipiplon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06582
Dextofisopam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06594
Agomelatine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06660
Saredutant may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06678
Esmirtazapine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06690
Nitrous oxide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06716
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06731
Seproxetine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06753
Triclofos may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06770
Benzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB06797
Mebutamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08059
Wortmannin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08329
Sulthiame may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08550
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08810
Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08811
Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08839
Serotonin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08872
Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08883
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08892
Arbaclofen Placarbil may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08910
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08927
Amperozide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08953
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08954
Ifenprodil may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08960
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08986
Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09000
Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09001
Barbexaclone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09011
Beclamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09014
Captodiame may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09017
Brotizolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09021
Benzoctamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09023
Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09034
Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09071
Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09072
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09117
Paraldehyde may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09119
Eslicarbazepine acetate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09166
Etizolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09184
Edivoxetine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09186
Nisoxetine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09187
Lortalamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09190
Talopram may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09241
Methylene blue may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09243
Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09246
Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09247
Iproclozide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09248
Mebanazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09249
Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09250
Pheniprazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09251
Phenoxypropazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09252
Pivhydrazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09253
Safrazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09254
Caroxazone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09289
Tianeptine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB09307
Oxaprotiline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11156
Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11371
Alfaxalone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11400
Doramectin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11428
Medetomidine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11477
Xylazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11540
Propiopromazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11543
Romifidine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11549
Tiletamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11552
Tricaine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11555
Zolazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11556
Detomidine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11582
Thiocolchicoside may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11664
Psilocybin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11675
Mosapride may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11686
Iferanserin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11732
Lasmiditan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11755
Tetrahydrocannabivarin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11823
Esketamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11859
Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11868
Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11889
Lanicemine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11957
Idalopirdine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12071
Vabicaserin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12105
Imagabalin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12110
m-Chlorophenylpiperazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12111
MK-212 may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12131
Vinpocetine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12163
Sarpogrelate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12177
Eplivanserin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12184
Gepirone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12229
Cerlapirdine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12308
Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12327
Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12338
Carisbamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12361
Piclozotan may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12395
Esreboxetine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12401
Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12427
Orvepitant may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12465
Ketanserin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12537
Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12576
AZD-3043 may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12590
Indiplon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12661
Urapidil may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12725
TD-8954 may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12833
Tandospirone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12883
Eltoprazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12951
Pivagabine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12958
Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12989
Neosaxitoxin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13014
Hypericin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13082
Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13099
Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13114
Amitriptylinoxide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13213
Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13219
Medifoxamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13221
Apronalide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13225
Dibenzepin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13233
Alaproclate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13234
Propanidid may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13246
Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13253
Proxibarbal may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13256
Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13295
Atracurium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13303
Febarbamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13323
Trichloroethylene may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13324
Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13331
Pyrithyldione may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13335
Pinazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13352
Deanol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13354
Phenprobamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13357
Styramate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13362
Pheneturide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13370
Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13377
Vinbarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13382
Chlorproethazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13384
Melitracen may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13396
Neocitrullamon may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13402
Acetylglycinamide chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13403
Oxypertine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13411
Lofepramine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13414
Fenyramidol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13420
Thiazinam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13437
Medazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13455
Phenibut may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13457
Oxaflozane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13496
Iprindole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13505
Emepronium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13520
Metergoline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13522
Mebicar may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13523
Veralipride may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13534
Gedocarnil may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13541
Iprazochrome may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13550
Bifemelane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13554
Moperone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13557
Thiopropazate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13572
Emylcamate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13577
Allobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13584
Gallamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13588
Naftidrofuryl may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13598
Diethyl ether may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13601
Oxiracetam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13623
Fabomotizole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13642
Pridinol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13643
Loprazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13648
Alcuronium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13662
Hexapropymate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13665
Fluanisone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13676
Mosapramine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13687
Niaprazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13690
Vinyl ether may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13733
Methylpentynol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13737
Cyclobarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13745
Fazadinium bromide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13754
Mephenoxalone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13770
Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13782
Imipramine oxide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13784
Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13799
Ethadione may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13805
Reposal may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13817
Carbromal may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13837
Doxefazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13872
Lormetazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13875
Harmaline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13876
Brofaromine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13948
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13984
Cyclopropane may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB13993
MRK-409 may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14010
5-methoxy-N,N-dimethyltryptamine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14028
Nordazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14050
Cannabidivarin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14185
Aripiprazole lauroxil may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14575
Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14651
Perphenazine enanthate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14672
Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14715
Cinazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14718
Pyrazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB14719
Bentazepam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB15203
JNJ-26489112 may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00967
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.
DB00653
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.
DB00206
Reserpine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00289
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Atomoxetine.
DB00341
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Cetirizine.
DB00377
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
DB00669
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Sumatriptan.
DB00918
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
DB00953
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Rizatriptan.
DB00960
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Pindolol.
DB01105
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Sibutramine.
DB01149
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Nefazodone.
DB01359
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Penbutolol.
DB01367
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
DB04896
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Milnacipran.
DB06700
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Desvenlafaxine.
DB08918
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran.
DB09068
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
DB09185
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
DB09194
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Etoperidone.
DB09244
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Pirlindole.
DB09245
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Toloxatone.
DB11699
Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Tropisetron.
DB00924
Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00252
Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01320
Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01437
Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01104
Sertraline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB11951
Lemborexant may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01142
Doxepin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01186
Pergolide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00344
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00532
Mephenytoin may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB01356
Lithium cation may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB08996
Dimetacrine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12930
Opipramol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB12404
Remimazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00751
Epinastine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00007
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Leuprolide.
DB00014
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Goserelin.
DB00195
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Betaxolol.
DB00199
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Erythromycin.
DB00207
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Azithromycin.
DB00218
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Moxifloxacin.
DB00263
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sulfisoxazole.
DB00343
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Diltiazem.
DB00393
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nimodipine.
DB00526
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Oxaliplatin.
DB00537
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ciprofloxacin.
DB00544
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fluorouracil.
DB00556
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Perflutren.
DB00568
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cinnarizine.
DB00571
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Propranolol.
DB00572
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Atropine.
DB00625
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Efavirenz.
DB00640
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Adenosine.
DB00738
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pentamidine.
DB00743
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gadobenic acid.
DB00748
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Carbinoxamine.
DB00757
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dolasetron.
DB00778
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Roxithromycin.
DB00779
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nalidixic acid.
DB00827
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cinoxacin.
DB00836
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Loperamide.
DB00889
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Granisetron.
DB00904
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ondansetron.
DB00922
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Levosimendan.
DB00976
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Telithromycin.
DB00978
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lomefloxacin.
DB00985
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dimenhydrinate.
DB01113
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Papaverine.
DB01114
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Chlorpheniramine.
DB01115
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nifedipine.
DB01137
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Levofloxacin.
DB01155
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gemifloxacin.
DB01165
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ofloxacin.
DB01193
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Acebutolol.
DB01211
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Clarithromycin.
DB01232
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Saquinavir.
DB01388
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Mibefradil.
DB01580
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Oxprenolol.
DB01599
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Probucol.
DB02638
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Terlipressin.
DB04825
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Prenylamine.
DB04948
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lofexidine.
DB04957
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Azimilide.
DB05223
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pracinostat.
DB05488
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Technetium Tc-99m ciprofloxacin.
DB06160
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Garenoxacin.
DB06200
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Tedisamil.
DB06334
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Tucidinostat.
DB06402
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Telavancin.
DB06589
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pazopanib.
DB06600
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nemonoxacin.
DB06712
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nilvadipine.
DB08799
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Antazoline.
DB08865
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Crizotinib.
DB08903
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bedaquiline.
DB08952
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Indenolol.
DB08980
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fendiline.
DB08992
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Eperisone.
DB09016
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Butriptyline.
DB09063
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ceritinib.
DB09078
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lenvatinib.
DB09231
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Benidipine.
DB09555
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dexchlorpheniramine maleate.
DB11640
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Amifampridine.
DB11830
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Mocetinostat.
DB11841
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Entinostat.
DB12141
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gilteritinib.
DB12174
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with CUDC-101.
DB12286
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Simendan.
DB12376
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ricolinostat.
DB12523
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Mizolastine.
DB12565
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Abexinostat.
DB12877
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Oxatomide.
DB13261
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sitafloxacin.
DB13500
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Otilonium.
DB13546
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nizofenone.
DB13652
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bunaftine.
DB13653
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lorcainide.
DB13679
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dexchlorpheniramine.
DB14063
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dexverapamil.
DB14568
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ivosidenib.
DB01084
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Emedastine.
DB11718
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Encorafenib.
DB00204
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dofetilide.
DB00215
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Citalopram.
DB00261
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Anagrelide.
DB00280
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Disopyramide.
DB00283
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Clemastine.
DB00308
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ibutilide.
DB00313
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Valproic acid.
DB00365
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Grepafloxacin.
DB00539
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Toremifene.
DB00619
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Imatinib.
DB00685
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Trovafloxacin.
DB00834
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Mifepristone.
DB00907
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cocaine.
DB01169
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Arsenic trioxide.
DB01208
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sparfloxacin.
DB01244
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bepridil.
DB01405
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Temafloxacin.
DB04844
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Tetrabenazine.
DB05294
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vandetanib.
DB06176
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Romidepsin.
DB06697
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Artemether.
DB09039
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Eliglustat.
DB09083
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ivabradine.
DB11730
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ribociclib.
DB11978
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Glasdegib.
DB12161
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Deutetrabenazine.
DB13725
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Terodiline.
DB01118
The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Benzatropine.
DB01087
The metabolism of Primaquine can be decreased when combined with Benzatropine.
DB00342
The metabolism of Terfenadine can be decreased when combined with Benzatropine.
DB00468
The metabolism of Quinine can be decreased when combined with Benzatropine.
DB04868
The metabolism of Nilotinib can be decreased when combined with Benzatropine.
DB06708
The metabolism of Lumefantrine can be decreased when combined with Benzatropine.
DB01079
The metabolism of Tegaserod can be decreased when combined with Benzatropine.
DB00091
The metabolism of Benzatropine can be decreased when combined with Cyclosporine.
DB00482
The metabolism of Benzatropine can be decreased when combined with Celecoxib.
DB00176
The metabolism of Benzatropine can be decreased when combined with Fluvoxamine.
DB00264
The metabolism of Metoprolol can be decreased when combined with Benzatropine.
DB00285
The metabolism of Venlafaxine can be decreased when combined with Benzatropine.
DB00349
The metabolism of Clobazam can be decreased when combined with Benzatropine.
DB00476
The metabolism of Duloxetine can be decreased when combined with Benzatropine.
DB00501
The metabolism of Cimetidine can be decreased when combined with Benzatropine.
DB00608
The metabolism of Chloroquine can be decreased when combined with Benzatropine.
DB00169
The metabolism of Benzatropine can be decreased when combined with Cholecalciferol.
DB00496
The metabolism of Benzatropine can be decreased when combined with Darifenacin.
DB00503
The metabolism of Benzatropine can be decreased when combined with Ritonavir.
DB00705
The metabolism of Benzatropine can be decreased when combined with Delavirdine.
DB00752
The metabolism of Benzatropine can be decreased when combined with Tranylcypromine.
DB00857
The metabolism of Benzatropine can be decreased when combined with Terbinafine.
DB00932
The metabolism of Benzatropine can be decreased when combined with Tipranavir.
DB01026
The metabolism of Benzatropine can be decreased when combined with Ketoconazole.
DB01074
The metabolism of Benzatropine can be decreased when combined with Perhexiline.
DB02703
The metabolism of Benzatropine can be decreased when combined with Fusidic acid.
DB05812
The metabolism of Benzatropine can be decreased when combined with Abiraterone.
DB06603
The metabolism of Benzatropine can be decreased when combined with Panobinostat.
DB06684
The metabolism of Benzatropine can be decreased when combined with Vilazodone.
DB06729
The metabolism of Benzatropine can be decreased when combined with Sulfaphenazole.
DB06819
The metabolism of Benzatropine can be decreased when combined with Phenylbutyric acid.
DB09238
The metabolism of Benzatropine can be decreased when combined with Manidipine.
DB09291
The metabolism of Benzatropine can be decreased when combined with Rolapitant.
DB11586
The metabolism of Benzatropine can be decreased when combined with Asunaprevir.
DB12332
The metabolism of Benzatropine can be decreased when combined with Rucaparib.
DB12693
The metabolism of Benzatropine can be decreased when combined with Ritanserin.
DB13174
The metabolism of Benzatropine can be decreased when combined with Rhein.
DB00458
The metabolism of Imipramine can be decreased when combined with Benzatropine.
DB01151
The metabolism of Desipramine can be decreased when combined with Benzatropine.
DB09167
The metabolism of Dosulepin can be decreased when combined with Benzatropine.
DB04871
The metabolism of Lorcaserin can be decreased when combined with Benzatropine.
DB00622
The metabolism of Benzatropine can be decreased when combined with Nicardipine.
DB15982
The metabolism of Benzatropine can be decreased when combined with Berotralstat.
DB00908
The metabolism of Quinidine can be decreased when combined with Benzatropine.
DB00604
The metabolism of Benzatropine can be decreased when combined with Cisapride.
DB00715
The metabolism of Benzatropine can be decreased when combined with Paroxetine.
DB01012
The metabolism of Benzatropine can be decreased when combined with Cinacalcet.
DB01173
The metabolism of Benzatropine can be decreased when combined with Orphenadrine.
DB01182
The metabolism of Benzatropine can be decreased when combined with Propafenone.
DB01218
The metabolism of Benzatropine can be decreased when combined with Halofantrine.
DB06595
The metabolism of Benzatropine can be decreased when combined with Midostaurin.
DB08909
The metabolism of Benzatropine can be decreased when combined with Glycerol phenylbutyrate.
DB08881
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vemurafenib.
DB11637
Benzatropine may increase the QTc-prolonging activities of Delamanid.
DB11642
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Benzatropine.
DB09532
The therapeutic efficacy of Secretin human can be decreased when used in combination with Benzatropine.
DB00354
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Buclizine.
DB00424
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Hyoscyamine.
DB01591
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Solifenacin.
DB00358
The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Benzatropine.
DB00674
The risk or severity of QTc prolongation can be increased when Galantamine is combined with Benzatropine.
DB00871
The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Benzatropine.
DB11390
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Benzatropine.
DB11397
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Benzatropine.
DB11412
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Benzatropine.
DB00104
The risk or severity of QTc prolongation can be increased when Octreotide is combined with Benzatropine.
DB00107
The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Benzatropine.
DB00187
The risk or severity of QTc prolongation can be increased when Esmolol is combined with Benzatropine.
DB00188
The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Benzatropine.
DB00346
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Alfuzosin.
DB00374
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Treprostinil.
DB00467
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Enoxacin.
DB00487
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pefloxacin.
DB00582
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Voriconazole.
DB00613
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Amodiaquine.
DB00678
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Losartan.
DB00691
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Moexipril.
DB00710
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ibandronate.
DB00719
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Azatadine.
DB00817
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Rosoxacin.
DB00822
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Disulfiram.
DB00825
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Levomenthol.
DB00862
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vardenafil.
DB00916
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Metronidazole.
DB00920
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ketotifen.
DB00927
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Famotidine.
DB00938
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Salmeterol.
DB00983
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Formoterol.
DB01044
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gatifloxacin.
DB01054
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nitrendipine.
DB01059
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Norfloxacin.
DB01158
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bretylium.
DB01228
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Encainide.
DB01254
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dasatinib.
DB01259
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lapatinib.
DB01263
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Posaconazole.
DB01268
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sunitinib.
DB01396
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Digitoxin.
DB01426
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ajmaline.
DB01620
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pheniramine.
DB02546
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vorinostat.
DB04576
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fleroxacin.
DB04695
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Farnesyl thiopyrophosphate.
DB04846
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Celiprolol.
DB05039
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Indacaterol.
DB05465
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Tandutinib.
DB06468
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cariporide.
DB06663
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pasireotide.
DB06699
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Degarelix.
DB06719
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Buserelin.
DB06788
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Histrelin.
DB06825
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Triptorelin.
DB07780
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Farnesyl diphosphate.
DB07841
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Geranylgeranyl diphosphate.
DB08808
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bupranolol.
DB08871
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Eribulin.
DB08912
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dabrafenib.
DB08936
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Chlorcyclizine.
DB08972
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Flumequine.
DB09080
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Olodaterol.
DB09090
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pinaverium.
DB09229
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Aranidipine.
DB09236
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lacidipine.
DB09239
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Niguldipine.
DB11408
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Famphur.
DB11443
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Orbifloxacin.
DB11448
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Phosmet.
DB11491
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sarafloxacin.
DB11511
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Difloxacin.
DB11591
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bilastine.
DB11614
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Rupatadine.
DB11742
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ebastine.
DB11770
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Talinolol.
DB11774
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pazufloxacin.
DB11785
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Anisodamine.
DB11891
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with CUDC-907.
DB11892
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Prulifloxacin.
DB12231
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Temefos.
DB12645
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Givinostat.
DB12712
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pilsicainide.
DB12923
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Gallopamil.
DB13358
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cibenzoline.
DB13488
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bencyclane.
DB13555
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Prajmaline.
DB13627
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Oxolinic acid.
DB13651
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lorajmine.
DB13691
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Acetyldigoxin.
DB13744
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Piromidic acid.
DB13766
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lidoflazine.
DB13772
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Rufloxacin.
DB13823
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pipemidic acid.
DB00196
The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Benzatropine.
DB00270
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Isradipine.
DB00373
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Timolol.
DB00915
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Amantadine.
DB01001
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Salbutamol.
DB01015
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sulfamethoxazole.
DB01036
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Tolterodine.
DB01166
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cilostazol.
DB01274
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Arformoterol.
DB09082
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vilanterol.
DB09089
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Trimebutine.
DB09488
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Acrivastine.
DB11943
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Delafloxacin.
DB01167
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Itraconazole.
DB01071
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Mequitazine.
DB00845
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Clofazimine.
DB11796
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fostemsavir.
DB11853
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Relugolix.
DB01156
The risk or severity of adverse effects can be increased when Bupropion is combined with Benzatropine.
DB00159
Icosapent may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00229
Cefotiam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00244
Mesalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00267
Cefmenoxime may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00274
Cefmetazole may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00282
Pamidronic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00300
Tenofovir disoproxil may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00328
Indomethacin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00369
Cidofovir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00384
Triamterene may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00430
Cefpiramide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00438
Ceftazidime may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00447
Loracarbef may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00456
Cefalotin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00461
Nabumetone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00465
Ketorolac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00469
Tenoxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00493
Cefotaxime may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00500
Tolmetin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00529
Foscarnet may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00533
Rofecoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00554
Piroxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00563
Methotrexate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00567
Cephalexin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00573
Fenoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00577
Valaciclovir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00580
Valdecoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00586
Diclofenac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00605
Sulindac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00626
Bacitracin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00681
Amphotericin B may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00689
Cephaloglycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00712
Flurbiprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00718
Adefovir dipivoxil may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00742
Mannitol may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00749
Etodolac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00784
Mefenamic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00787
Acyclovir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00788
Naproxen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00795
Sulfasalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00812
Phenylbutazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00814
Meloxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00821
Carprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00833
Cefaclor may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00861
Diflunisal may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00864
Tacrolimus may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00903
Etacrynic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00923
Ceforanide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00936
Salicylic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00939
Meclofenamic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00945
Acetylsalicylic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00958
Carboplatin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00991
Oxaprozin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00999
Hydrochlorothiazide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01009
Ketoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01014
Balsalazide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01050
Ibuprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01066
Cefditoren may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01072
Atazanavir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01111
Colistimethate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01112
Cefuroxime may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01139
Cefapirin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01140
Cefadroxil may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01150
Cefprozil may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01212
Ceftriaxone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01250
Olsalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01283
Lumiracoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01326
Cefamandole may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01327
Cefazolin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01328
Cefonicid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01329
Cefoperazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01330
Cefotetan may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01331
Cefoxitin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01332
Ceftizoxime may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01333
Cefradine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01397
Magnesium salicylate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01399
Salsalate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01401
Choline magnesium trisalicylate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01413
Cefepime may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01414
Cefacetrile may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01415
Ceftibuten may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01416
Cefpodoxime may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01419
Antrafenine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01424
Aminophenazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01600
Tiaprofenic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01628
Etoricoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB02247
Hydrolyzed Cephalothin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB03450
Cephalothin Group may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB03585
Oxyphenbutazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04570
Latamoxef may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04743
Nimesulide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04812
Benoxaprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04817
Metamizole may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04828
Zomepirac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04918
Ceftobiprole may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB05095
Cimicoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB06590
Ceftaroline fosamil may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB06725
Lornoxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB06736
Aceclofenac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB06737
Zaltoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB07402
Azapropazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08439
Parecoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08797
Salicylamide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08940
Kebuzone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08942
Isoxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08951
Indoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08955
Ibuproxam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08976
Floctafenine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08981
Fenbufen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08984
Etofenamate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08991
Epirizole may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09008
Cefaloridine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09062
Cefminox may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09084
Benzydamine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09213
Dexibuprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09214
Dexketoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09215
Droxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09216
Tolfenamic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09217
Firocoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09218
Clonixin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09285
Morniflumate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09288
Propacetamol may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09295
Talniflumate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09299
Tenofovir alafenamide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB11367
Cefroxadine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB11455
Robenacoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB11466
Tepoxalin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB11518
Flunixin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB11935
Flomoxef may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB12151
Brincidofovir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB12445
Nitroaspirin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB12545
Indobufen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13001
Tinoridine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13167
Alclofenac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13217
Fentiazac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13232
Suxibuzone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13266
Cefatrizine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13286
Bumadizone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13314
Alminoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13371
Difenpiramide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13407
Nifenazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13432
Lonazolac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13461
Cefcapene may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13470
Cefodizime may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13481
Tenidap may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13499
Cefsulodin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13504
Cefetamet may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13524
Propyphenazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13527
Proglumetacin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13538
Guacetisal may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13544
Ethenzamide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13612
Carbaspirin calcium may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13629
Mofebutazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13638
Cefbuperazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13649
Proquazone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13657
Benorilate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13667
Cefozopran may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13682
Cefpirome may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13722
Pirprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13778
Cefazedone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13783
Acemetacin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13821
Ceftezole may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13860
Imidazole salicylate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13868
Adefovir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB14059
SC-236 may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB14060
NS-398 may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB14126
Tenofovir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB14713
Inotersen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01438
Phenazopyridine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01435
Benzatropine may decrease the excretion rate of Antipyrine which could result in a higher serum level.
DB01601
Lopinavir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB14507
Lithium citrate may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB09212
Loxoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00452
Framycetin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01421
Paromomycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04263
Geneticin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04626
Apramycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04808
Neamine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB08437
Puromycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB11512
Dihydrostreptomycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB11520
Hygromycin B may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01046
Benzatropine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
DB01638
Benzatropine may decrease the excretion rate of Sorbitol which could result in a higher serum level.
DB06480
Benzatropine may decrease the excretion rate of Prucalopride which could result in a higher serum level.
DB09104
Benzatropine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
DB09219
Benzatropine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.
DB09268
Benzatropine may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
DB09281
Benzatropine may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.
DB09472
Benzatropine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.
DB09481
Benzatropine may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
DB14499
Benzatropine may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
DB00017
Salmon calcitonin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00035
Desmopressin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00041
Aldesleukin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00080
Daptomycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00081
Tositumomab may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00115
Cyanocobalamin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00158
Folic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00165
Pyridoxine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00185
Cevimeline may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00190
Carbidopa may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00198
Oseltamivir may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00200
Hydroxocobalamin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00213
Pantoprazole may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00225
Gadodiamide may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00235
Milrinone may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00254
Benzatropine may decrease the excretion rate of Doxycycline which could result in a higher serum level.
DB00262
Benzatropine may decrease the excretion rate of Carmustine which could result in a higher serum level.
DB00271
Benzatropine may decrease the excretion rate of Diatrizoate which could result in a higher serum level.
DB00279
Benzatropine may decrease the excretion rate of Liothyronine which could result in a higher serum level.
DB00284
Benzatropine may decrease the excretion rate of Acarbose which could result in a higher serum level.
DB00286
Benzatropine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
DB00290
Benzatropine may decrease the excretion rate of Bleomycin which could result in a higher serum level.
DB00294
Benzatropine may decrease the excretion rate of Etonogestrel which could result in a higher serum level.
DB00296
Benzatropine may decrease the excretion rate of Ropivacaine which could result in a higher serum level.
DB00303
Benzatropine may decrease the excretion rate of Ertapenem which could result in a higher serum level.
DB00316
Benzatropine may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
DB00319
Benzatropine may decrease the excretion rate of Piperacillin which could result in a higher serum level.
DB00322
Benzatropine may decrease the excretion rate of Floxuridine which could result in a higher serum level.
DB00325
Benzatropine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.
DB00330
Benzatropine may decrease the excretion rate of Ethambutol which could result in a higher serum level.
DB00331
Benzatropine may decrease the excretion rate of Metformin which could result in a higher serum level.
DB00339
Benzatropine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
DB00351
Benzatropine may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.
DB00355
Benzatropine may decrease the excretion rate of Aztreonam which could result in a higher serum level.
DB00359
Benzatropine may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
DB00364
Benzatropine may decrease the excretion rate of Sucralfate which could result in a higher serum level.
DB00380
Benzatropine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
DB00401
Benzatropine may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
DB00413
Benzatropine may decrease the excretion rate of Pramipexole which could result in a higher serum level.
DB00415
Benzatropine may decrease the excretion rate of Ampicillin which could result in a higher serum level.
DB00432
Benzatropine may decrease the excretion rate of Trifluridine which could result in a higher serum level.
DB00435
Benzatropine may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.
DB00437
Benzatropine may decrease the excretion rate of Allopurinol which could result in a higher serum level.
DB00440
Benzatropine may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
DB00441
Benzatropine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
DB00480
Benzatropine may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
DB00492
Benzatropine may decrease the excretion rate of Fosinopril which could result in a higher serum level.
DB00499
Benzatropine may decrease the excretion rate of Flutamide which could result in a higher serum level.
DB00535
Benzatropine may decrease the excretion rate of Cefdinir which could result in a higher serum level.
DB00548
Benzatropine may decrease the excretion rate of Azelaic acid which could result in a higher serum level.
DB00553
Benzatropine may decrease the excretion rate of Methoxsalen which could result in a higher serum level.
DB00558
Benzatropine may decrease the excretion rate of Zanamivir which could result in a higher serum level.
DB00569
Benzatropine may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
DB00583
Benzatropine may decrease the excretion rate of Levocarnitine which could result in a higher serum level.
DB00591
Benzatropine may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.
DB00597
Benzatropine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.
DB00603
Benzatropine may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.
DB00612
Benzatropine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
DB00624
Benzatropine may decrease the excretion rate of Testosterone which could result in a higher serum level.
DB00631
Benzatropine may decrease the excretion rate of Clofarabine which could result in a higher serum level.
DB00635
Benzatropine may decrease the excretion rate of Prednisone which could result in a higher serum level.
DB00651
Benzatropine may decrease the excretion rate of Dyphylline which could result in a higher serum level.
DB00657
Benzatropine may decrease the excretion rate of Mecamylamine which could result in a higher serum level.
DB00665
Benzatropine may decrease the excretion rate of Nilutamide which could result in a higher serum level.
DB00672
Benzatropine may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
DB00688
Benzatropine may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
DB00692
Benzatropine may decrease the excretion rate of Phentolamine which could result in a higher serum level.
DB00698
Benzatropine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
DB00706
Benzatropine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
DB00709
Benzatropine may decrease the excretion rate of Lamivudine which could result in a higher serum level.
DB00713
Benzatropine may decrease the excretion rate of Oxacillin which could result in a higher serum level.
DB00716
Benzatropine may decrease the excretion rate of Nedocromil which could result in a higher serum level.
DB00722
Benzatropine may decrease the excretion rate of Lisinopril which could result in a higher serum level.
DB00730
Benzatropine may decrease the excretion rate of Thiabendazole which could result in a higher serum level.
DB00731
Benzatropine may decrease the excretion rate of Nateglinide which could result in a higher serum level.
DB00733
Benzatropine may decrease the excretion rate of Pralidoxime which could result in a higher serum level.
DB00759
Benzatropine may decrease the excretion rate of Tetracycline which could result in a higher serum level.
DB00760
Benzatropine may decrease the excretion rate of Meropenem which could result in a higher serum level.
DB00775
Benzatropine may decrease the excretion rate of Tirofiban which could result in a higher serum level.
DB00782
Benzatropine may decrease the excretion rate of Propantheline which could result in a higher serum level.
DB00783
Benzatropine may decrease the excretion rate of Estradiol which could result in a higher serum level.
DB00789
Benzatropine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.
DB00800
Benzatropine may decrease the excretion rate of Fenoldopam which could result in a higher serum level.
DB00804
Benzatropine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
DB00806
Benzatropine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
DB00811
Benzatropine may decrease the excretion rate of Ribavirin which could result in a higher serum level.
DB00820
Benzatropine may decrease the excretion rate of Tadalafil which could result in a higher serum level.
DB00828
Benzatropine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
DB00839
Benzatropine may decrease the excretion rate of Tolazamide which could result in a higher serum level.
DB00841
Benzatropine may decrease the excretion rate of Dobutamine which could result in a higher serum level.
DB00851
Benzatropine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
DB00853
Benzatropine may decrease the excretion rate of Temozolomide which could result in a higher serum level.
DB00894
Benzatropine may decrease the excretion rate of Testolactone which could result in a higher serum level.
DB00900
Benzatropine may decrease the excretion rate of Didanosine which could result in a higher serum level.
DB00911
Benzatropine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
DB00928
Benzatropine may decrease the excretion rate of Azacitidine which could result in a higher serum level.
DB00951
Benzatropine may decrease the excretion rate of Isoniazid which could result in a higher serum level.
DB00961
Benzatropine may decrease the excretion rate of Mepivacaine which could result in a higher serum level.
DB00968
Benzatropine may decrease the excretion rate of Methyldopa which could result in a higher serum level.
DB00988
Benzatropine may decrease the excretion rate of Dopamine which could result in a higher serum level.
DB00993
Benzatropine may decrease the excretion rate of Azathioprine which could result in a higher serum level.
DB00995
Benzatropine may decrease the excretion rate of Auranofin which could result in a higher serum level.
DB01002
Benzatropine may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.
DB01004
Benzatropine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
DB01011
Benzatropine may decrease the excretion rate of Metyrapone which could result in a higher serum level.
DB01020
Benzatropine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.
DB01022
Benzatropine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
DB01024
Benzatropine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
DB01030
Benzatropine may decrease the excretion rate of Topotecan which could result in a higher serum level.
DB01032
Benzatropine may decrease the excretion rate of Probenecid which could result in a higher serum level.
DB01039
Benzatropine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
DB01048
Benzatropine may decrease the excretion rate of Abacavir which could result in a higher serum level.
DB01060
Benzatropine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
DB01067
Benzatropine may decrease the excretion rate of Glipizide which could result in a higher serum level.
DB01099
Benzatropine may decrease the excretion rate of Flucytosine which could result in a higher serum level.
DB01101
Benzatropine may decrease the excretion rate of Capecitabine which could result in a higher serum level.
DB01124
Benzatropine may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
DB01129
Benzatropine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
DB01133
Benzatropine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.
DB01148
Benzatropine may decrease the excretion rate of Flavoxate which could result in a higher serum level.
DB01157
Benzatropine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.
DB01170
Benzatropine may decrease the excretion rate of Guanethidine which could result in a higher serum level.
DB01181
Benzatropine may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
DB01183
Benzatropine may decrease the excretion rate of Naloxone which could result in a higher serum level.
DB01203
Benzatropine may decrease the excretion rate of Nadolol which could result in a higher serum level.
DB01205
Benzatropine may decrease the excretion rate of Flumazenil which could result in a higher serum level.
DB01213
Benzatropine may decrease the excretion rate of Fomepizole which could result in a higher serum level.
DB01222
Benzatropine may decrease the excretion rate of Budesonide which could result in a higher serum level.
DB01240
Benzatropine may decrease the excretion rate of Epoprostenol which could result in a higher serum level.
DB01241
Benzatropine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
DB01249
Benzatropine may decrease the excretion rate of Iodixanol which could result in a higher serum level.
DB01261
Benzatropine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
DB01273
Benzatropine may decrease the excretion rate of Varenicline which could result in a higher serum level.
DB01275
Benzatropine may decrease the excretion rate of Hydralazine which could result in a higher serum level.
DB01394
Benzatropine may decrease the excretion rate of Colchicine which could result in a higher serum level.
DB01420
Benzatropine may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
DB01427
Benzatropine may decrease the excretion rate of Amrinone which could result in a higher serum level.
DB01428
Benzatropine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.
DB01431
Benzatropine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.
DB01550
Benzatropine may decrease the excretion rate of Fenproporex which could result in a higher serum level.
DB01610
Benzatropine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
DB01656
Benzatropine may decrease the excretion rate of Roflumilast which could result in a higher serum level.
DB01685
Benzatropine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.
DB04574
Benzatropine may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.
DB04895
Benzatropine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
DB04920
Benzatropine may decrease the excretion rate of Clevidipine which could result in a higher serum level.
DB05018
Benzatropine may decrease the excretion rate of Migalastat which could result in a higher serum level.
DB06154
Benzatropine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.
DB06186
Benzatropine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
DB06196
Benzatropine may decrease the excretion rate of Icatibant which could result in a higher serum level.
DB06203
Benzatropine may decrease the excretion rate of Alogliptin which could result in a higher serum level.
DB06209
Benzatropine may decrease the excretion rate of Prasugrel which could result in a higher serum level.
DB06211
Benzatropine may decrease the excretion rate of Doripenem which could result in a higher serum level.
DB06228
Benzatropine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
DB06230
Benzatropine may decrease the excretion rate of Nalmefene which could result in a higher serum level.
DB06262
Benzatropine may decrease the excretion rate of Droxidopa which could result in a higher serum level.
DB06335
Benzatropine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
DB06623
Benzatropine may decrease the excretion rate of Flupirtine which could result in a higher serum level.
DB06637
Benzatropine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
DB06695
Benzatropine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.
DB06702
Benzatropine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
DB06705
Benzatropine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.
DB06710
Benzatropine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.
DB06767
Benzatropine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.
DB06782
Benzatropine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
DB06796
Benzatropine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.
DB06800
Benzatropine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
DB06809
Benzatropine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
DB06813
Benzatropine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
DB06823
Benzatropine may decrease the excretion rate of Tiopronin which could result in a higher serum level.
DB06824
Benzatropine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
DB08826
Benzatropine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
DB08840
Benzatropine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.
DB08877
Benzatropine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
DB08894
Benzatropine may decrease the excretion rate of Peginesatide which could result in a higher serum level.
DB08900
Benzatropine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
DB08905
Benzatropine may decrease the excretion rate of Formestane which could result in a higher serum level.
DB08911
Benzatropine may decrease the excretion rate of Trametinib which could result in a higher serum level.
DB08932
Benzatropine may decrease the excretion rate of Macitentan which could result in a higher serum level.
DB08934
Benzatropine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
DB09027
Benzatropine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.
DB09050
Benzatropine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.
DB09066
Benzatropine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.
DB09075
Benzatropine may decrease the excretion rate of Edoxaban which could result in a higher serum level.
DB09081
Benzatropine may decrease the excretion rate of Idebenone which could result in a higher serum level.
DB09091
Benzatropine may decrease the excretion rate of Tixocortol which could result in a higher serum level.
DB09103
Benzatropine may decrease the excretion rate of Ancestim which could result in a higher serum level.
DB09106
Benzatropine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.
DB09111
Benzatropine may decrease the excretion rate of Pentastarch which could result in a higher serum level.
DB09121
Benzatropine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.
DB09123
Benzatropine may decrease the excretion rate of Dienogest which could result in a higher serum level.
DB09129
Benzatropine may decrease the excretion rate of Chromic chloride which could result in a higher serum level.
DB09132
Benzatropine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.
DB09133
Benzatropine may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
DB09134
Benzatropine may decrease the excretion rate of Ioversol which could result in a higher serum level.
DB09135
Benzatropine may decrease the excretion rate of Ioxilan which could result in a higher serum level.
DB09136
Benzatropine may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.
DB09137
Benzatropine may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.
DB09139
Benzatropine may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.
DB09148
Benzatropine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.
DB09149
Benzatropine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.
DB09156
Benzatropine may decrease the excretion rate of Iopromide which could result in a higher serum level.
DB09163
Benzatropine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.
DB09165
Benzatropine may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.
DB09195
Benzatropine may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.
DB09204
Benzatropine may decrease the excretion rate of Arotinolol which could result in a higher serum level.
DB09205
Benzatropine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.
DB09209
Benzatropine may decrease the excretion rate of Pholcodine which could result in a higher serum level.
DB09210
Benzatropine may decrease the excretion rate of Piracetam which could result in a higher serum level.
DB09220
Benzatropine may decrease the excretion rate of Nicorandil which could result in a higher serum level.
DB09255
Benzatropine may decrease the excretion rate of Dextran which could result in a higher serum level.
DB09256
Benzatropine may decrease the excretion rate of Tegafur which could result in a higher serum level.
DB09257
Benzatropine may decrease the excretion rate of Gimeracil which could result in a higher serum level.
DB09262
Benzatropine may decrease the excretion rate of Imidafenacin which could result in a higher serum level.
DB09264
Benzatropine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
DB09265
Benzatropine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
DB09276
Benzatropine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.
DB09277
Benzatropine may decrease the excretion rate of Choline C 11 which could result in a higher serum level.
DB09292
Benzatropine may decrease the excretion rate of Sacubitril which could result in a higher serum level.
DB09301
Benzatropine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
DB09317
Benzatropine may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.
DB09318
Benzatropine may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.
DB09320
Benzatropine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
DB09324
Benzatropine may decrease the excretion rate of Sulbactam which could result in a higher serum level.
DB09325
Benzatropine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
DB09329
Benzatropine may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.
DB09344
Benzatropine may decrease the excretion rate of Invert sugar which could result in a higher serum level.
DB09357
Benzatropine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
DB09394
Benzatropine may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
DB09395
Benzatropine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
DB09407
Benzatropine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
DB09418
Benzatropine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.
DB09477
Benzatropine may decrease the excretion rate of Enalaprilat which could result in a higher serum level.
DB09496
Benzatropine may decrease the excretion rate of Octinoxate which could result in a higher serum level.
DB09502
Benzatropine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.
DB09546
Benzatropine may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.
DB09570
Benzatropine may decrease the excretion rate of Ixazomib which could result in a higher serum level.
DB11077
Benzatropine may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.
DB11098
Benzatropine may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.
DB11102
Benzatropine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.
DB11114
Benzatropine may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.
DB11127
Benzatropine may decrease the excretion rate of Selenious acid which could result in a higher serum level.
DB11135
Benzatropine may decrease the excretion rate of Selenium which could result in a higher serum level.
DB11136
Benzatropine may decrease the excretion rate of Chromium which could result in a higher serum level.
DB11145
Benzatropine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.
DB11164
Benzatropine may decrease the excretion rate of Bicisate which could result in a higher serum level.
DB11251
Benzatropine may decrease the excretion rate of Tocopherol which could result in a higher serum level.
DB11278
Benzatropine may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.
DB11328
Benzatropine may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.
DB11338
Benzatropine may decrease the excretion rate of Clove oil which could result in a higher serum level.
DB11358
Benzatropine may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.
DB11364
Benzatropine may decrease the excretion rate of Pidotimod which could result in a higher serum level.
DB11560
Benzatropine may decrease the excretion rate of Lesinurad which could result in a higher serum level.
DB11577
Benzatropine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.
DB11587
Benzatropine may decrease the excretion rate of Etafedrine which could result in a higher serum level.
DB11598
Benzatropine may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.
DB11691
Benzatropine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
DB11817
Benzatropine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
DB11901
Benzatropine may decrease the excretion rate of Apalutamide which could result in a higher serum level.
DB11915
Benzatropine may decrease the excretion rate of Valbenazine which could result in a higher serum level.
DB11989
Benzatropine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
DB12007
Benzatropine may decrease the excretion rate of Isoflavone which could result in a higher serum level.
DB12107
Benzatropine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
DB12278
Benzatropine may decrease the excretion rate of Propiverine which could result in a higher serum level.
DB12783
Benzatropine may decrease the excretion rate of Benserazide which could result in a higher serum level.
DB13156
Benzatropine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.
DB13178
Benzatropine may decrease the excretion rate of Inositol which could result in a higher serum level.
DB13185
Benzatropine may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.
DB13191
Benzatropine may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.
DB13269
Benzatropine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.
DB13293
Benzatropine may decrease the excretion rate of Ipecac which could result in a higher serum level.
DB13595
Benzatropine may decrease the excretion rate of Almasilate which could result in a higher serum level.
DB13873
Benzatropine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
DB13884
Benzatropine may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
DB13909
Benzatropine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
DB13943
Benzatropine may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
DB13944
Benzatropine may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
DB13946
Benzatropine may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
DB13952
Benzatropine may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
DB13954
Benzatropine may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
DB13955
Benzatropine may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.
DB13956
Benzatropine may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
DB13967
Benzatropine may decrease the excretion rate of Patent Blue which could result in a higher serum level.
DB14006
Benzatropine may decrease the excretion rate of Choline salicylate which could result in a higher serum level.
DB14007
Benzatropine may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
DB14498
Benzatropine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
DB14526
Benzatropine may decrease the excretion rate of Chromic citrate which could result in a higher serum level.
DB14527
Benzatropine may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.
DB14528
Benzatropine may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.
DB14529
Benzatropine may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
DB14530
Benzatropine may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.
DB06815
Benzatropine may decrease the excretion rate of Pyrithione which could result in a higher serum level.
DB11121
Benzatropine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.
DB08899
Benzatropine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
DB11085
Benzatropine may decrease the excretion rate of Resorcinol which could result in a higher serum level.
DB11090
Benzatropine may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.
DB15593
Benzatropine may decrease the excretion rate of Golodirsen which could result in a higher serum level.
DB00879
Benzatropine may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
DB14506
Benzatropine may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
DB00790
Benzatropine may decrease the excretion rate of Perindopril which could result in a higher serum level.
DB13987
Benzatropine may decrease the excretion rate of Strontium chloride which could result in a higher serum level.
DB04890
Benzatropine may decrease the excretion rate of Bepotastine which could result in a higher serum level.
DB00982
Benzatropine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
DB04930
Benzatropine may decrease the excretion rate of Permethrin which could result in a higher serum level.
DB09095
Benzatropine may decrease the excretion rate of Difluocortolone which could result in a higher serum level.
DB00515
Cisplatin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00479
Amikacin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00684
Tobramycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00798
Gentamicin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00955
Netilmicin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00994
Neomycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01082
Streptomycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB01172
Kanamycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB03615
Ribostamycin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB04729
Gentamicin C1a may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB06696
Arbekacin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB12604
Sisomicin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB13540
Isepamicin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00552
Benzatropine may decrease the excretion rate of Pentostatin which could result in a higher serum level.
DB13145
Benzatropine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
DB00314
Benzatropine may decrease the excretion rate of Capreomycin which could result in a higher serum level.
DB00390
Benzatropine may decrease the excretion rate of Digoxin which could result in a higher serum level.
DB00512
Benzatropine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
DB00564
Benzatropine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
DB00642
Benzatropine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
DB00682
Benzatropine may decrease the excretion rate of Warfarin which could result in a higher serum level.
DB12615
Benzatropine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
DB14509
Benzatropine may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
DB00803
Colistin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00232
Benzatropine may increase the excretion rate of Methyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00310
Benzatropine may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy.
DB00436
Benzatropine may increase the excretion rate of Bendroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00562
Benzatropine may increase the excretion rate of Benzthiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00774
Benzatropine may increase the excretion rate of Hydroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00880
Benzatropine may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB01021
Benzatropine may increase the excretion rate of Trichlormethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB01324
Benzatropine may increase the excretion rate of Polythiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB01325
Benzatropine may increase the excretion rate of Quinethazone which could result in a lower serum level and potentially a reduction in efficacy.
DB13532
Benzatropine may increase the excretion rate of Cyclopenthiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB13989
Benzatropine may increase the excretion rate of Epitizide which could result in a lower serum level and potentially a reduction in efficacy.
DB09235
Benzatropine may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy.
DB12766
Benzatropine may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy.
DB00524
Benzatropine may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
DB00695
Benzatropine may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00808
Benzatropine may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00887
Benzatropine may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
DB08907
Benzatropine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
DB09338
Benzatropine may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
DB00214
Torasemide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB00311
Ethoxzolamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB00421
Spironolactone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB00594
Amiloride may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB00606
Cyclothiazide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB00700
Eplerenone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB00872
Conivaptan may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB01119
Diazoxide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB01144
Diclofenamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB01395
Drospirenone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB01412
Theobromine may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB02925
Piretanide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB04831
Tienilic acid may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB05034
Ularitide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB06212
Tolvaptan may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB08961
Azosemide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB09015
Canrenoic acid may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB09125
Potassium citrate may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB09401
Isosorbide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB11827
Ertugliflozin may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB12221
Canrenone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB12670
Rolofylline may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB12704
Spiradoline may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13284
Meticrane may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13405
Mefruside may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13430
Mebutizide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13617
Clorexolone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13663
Clofenamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13708
Fenquizone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13792
Clopamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13801
Muzolimine may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB13803
Xipamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB14018
Bromotheophylline may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB14500
Potassium may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB06292
Benzatropine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
DB00703
Methazolamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
DB01345
Benzatropine may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy.
DB01062
The metabolism of Oxybutynin can be decreased when combined with Benzatropine.
DB01023
The metabolism of Felodipine can be decreased when combined with Benzatropine.
DB14009
The metabolism of Medical Cannabis can be decreased when combined with Benzatropine.
DB00208
The metabolism of Benzatropine can be decreased when combined with Ticlopidine.
DB00661
The metabolism of Verapamil can be decreased when combined with Benzatropine.
DB00763
The metabolism of Methimazole can be decreased when combined with Benzatropine.
DB01093
The metabolism of Dimethyl sulfoxide can be decreased when combined with Benzatropine.
DB06691
The metabolism of Benzatropine can be decreased when combined with Mepyramine.
DB00281
The metabolism of Benzatropine can be decreased when combined with Lidocaine.
DB00398
The metabolism of Benzatropine can be decreased when combined with Sorafenib.
DB00412
The metabolism of Benzatropine can be decreased when combined with Rosiglitazone.
DB00439
The metabolism of Benzatropine can be decreased when combined with Cerivastatin.
DB00574
The metabolism of Benzatropine can be decreased when combined with Fenfluramine.
DB00598
The metabolism of Benzatropine can be decreased when combined with Labetalol.
DB00633
The metabolism of Benzatropine can be decreased when combined with Dexmedetomidine.
DB00780
The metabolism of Benzatropine can be decreased when combined with Phenelzine.
DB00792
The metabolism of Benzatropine can be decreased when combined with Tripelennamine.
DB00810
The metabolism of Benzatropine can be decreased when combined with Biperiden.
DB00997
The metabolism of Benzatropine can be decreased when combined with Doxorubicin.
DB01005
The metabolism of Benzatropine can be decreased when combined with Hydroxyurea.
DB01075
The metabolism of Benzatropine can be decreased when combined with Diphenhydramine.
DB01110
The metabolism of Benzatropine can be decreased when combined with Miconazole.
DB01128
The metabolism of Benzatropine can be decreased when combined with Bicalutamide.
DB01171
The metabolism of Benzatropine can be decreased when combined with Moclobemide.
DB01611
The metabolism of Benzatropine can be decreased when combined with Hydroxychloroquine.
DB04818
The metabolism of Benzatropine can be decreased when combined with Iproniazid.
DB04884
The metabolism of Benzatropine can be decreased when combined with Dapoxetine.
DB05271
The metabolism of Benzatropine can be decreased when combined with Rotigotine.
DB06217
The metabolism of Benzatropine can be decreased when combined with Vernakalant.
DB06370
The metabolism of Benzatropine can be decreased when combined with Indisulam.
DB06412
The metabolism of Benzatropine can be decreased when combined with Oxymetholone.
DB06654
The metabolism of Benzatropine can be decreased when combined with Safinamide.
DB06727
The metabolism of Benzatropine can be decreased when combined with Sparteine.
DB08864
The metabolism of Benzatropine can be decreased when combined with Rilpivirine.
DB09049
The metabolism of Benzatropine can be decreased when combined with Naloxegol.
DB09118
The metabolism of Benzatropine can be decreased when combined with Stiripentol.
DB11633
The metabolism of Benzatropine can be decreased when combined with Isavuconazole.
DB11638
The metabolism of Benzatropine can be decreased when combined with Artenimol.
DB11753
The metabolism of Benzatropine can be decreased when combined with Rifamycin.
DB11994
The metabolism of Benzatropine can be decreased when combined with Diacerein.
DB12245
The metabolism of Benzatropine can be decreased when combined with Triclabendazole.
DB13139
The metabolism of Benzatropine can be decreased when combined with Levosalbutamol.
DB13975
The metabolism of Benzatropine can be decreased when combined with Black cohosh.
DB00220
The metabolism of Benzatropine can be decreased when combined with Nelfinavir.
DB01096
The metabolism of Benzatropine can be decreased when combined with Oxamniquine.
DB00528
The metabolism of Benzatropine can be decreased when combined with Lercanidipine.
DB01562
The metabolism of Benzatropine can be decreased when combined with 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine.
DB14635
The metabolism of Benzatropine can be decreased when combined with Curcumin sulfate.
DB01590
The metabolism of Benzatropine can be decreased when combined with Everolimus.
DB00863
The metabolism of Benzatropine can be decreased when combined with Ranitidine.
DB00627
The metabolism of Benzatropine can be decreased when combined with Niacin.
DB12500
The metabolism of Benzatropine can be decreased when combined with Fedratinib.
DB00022
The metabolism of Benzatropine can be decreased when combined with Peginterferon alfa-2b.
DB00227
The metabolism of Benzatropine can be decreased when combined with Lovastatin.
DB00238
The metabolism of Benzatropine can be decreased when combined with Nevirapine.
DB00317
The metabolism of Benzatropine can be decreased when combined with Gefitinib.
DB00338
The metabolism of Benzatropine can be decreased when combined with Omeprazole.
DB00361
The metabolism of Benzatropine can be decreased when combined with Vinorelbine.
DB00448
The metabolism of Benzatropine can be decreased when combined with Lansoprazole.
DB00570
The metabolism of Benzatropine can be decreased when combined with Vinblastine.
DB01131
The metabolism of Benzatropine can be decreased when combined with Proguanil.
DB01191
The metabolism of Benzatropine can be decreased when combined with Dexfenfluramine.
DB04938
The metabolism of Benzatropine can be decreased when combined with Ospemifene.
DB06287
The metabolism of Benzatropine can be decreased when combined with Temsirolimus.
DB09065
The metabolism of Benzatropine can be decreased when combined with Cobicistat.
DB11837
The metabolism of Benzatropine can be decreased when combined with Osilodrostat.
DB04911
The metabolism of Benzatropine can be decreased when combined with Oritavancin.
DB00184
The metabolism of Benzatropine can be decreased when combined with Nicotine.
DB00203
The metabolism of Benzatropine can be decreased when combined with Sildenafil.
DB00297
The metabolism of Bupivacaine can be decreased when combined with Benzatropine.
DB00335
The metabolism of Atenolol can be decreased when combined with Benzatropine.
DB00379
The metabolism of Mexiletine can be decreased when combined with Benzatropine.
DB00396
The metabolism of Progesterone can be decreased when combined with Benzatropine.
DB00590
The metabolism of Doxazosin can be decreased when combined with Benzatropine.
DB00592
The metabolism of Piperazine can be decreased when combined with Benzatropine.
DB00641
The metabolism of Simvastatin can be decreased when combined with Benzatropine.
DB00699
The metabolism of Nicergoline can be decreased when combined with Benzatropine.
DB00701
The metabolism of Amprenavir can be decreased when combined with Benzatropine.
DB00914
The metabolism of Phenformin can be decreased when combined with Benzatropine.
DB01095
The metabolism of Fluvastatin can be decreased when combined with Benzatropine.
DB01136
The metabolism of Carvedilol can be decreased when combined with Benzatropine.
DB01177
The metabolism of Idarubicin can be decreased when combined with Benzatropine.
DB01295
The metabolism of Bevantolol can be decreased when combined with Benzatropine.
DB01297
The metabolism of Practolol can be decreased when combined with Benzatropine.
DB01429
The metabolism of Aprindine can be decreased when combined with Benzatropine.
DB03783
The metabolism of Phenacetin can be decreased when combined with Benzatropine.
DB04840
The metabolism of Debrisoquine can be decreased when combined with Benzatropine.
DB04861
The metabolism of Nebivolol can be decreased when combined with Benzatropine.
DB04905
The metabolism of Tesmilifene can be decreased when combined with Benzatropine.
DB06608
The metabolism of Tafenoquine can be decreased when combined with Benzatropine.
DB06726
The metabolism of Bufuralol can be decreased when combined with Benzatropine.
DB06735
The metabolism of Enclomiphene can be decreased when combined with Benzatropine.
DB08807
The metabolism of Bopindolol can be decreased when combined with Benzatropine.
DB09048
The metabolism of Netupitant can be decreased when combined with Benzatropine.
DB09053
The metabolism of Ibrutinib can be decreased when combined with Benzatropine.
DB09183
The metabolism of Dasabuvir can be decreased when combined with Benzatropine.
DB09351
The metabolism of Levobetaxolol can be decreased when combined with Benzatropine.
DB11855
The metabolism of Revefenacin can be decreased when combined with Benzatropine.
DB11979
The metabolism of Elagolix can be decreased when combined with Benzatropine.
DB12070
The metabolism of Letermovir can be decreased when combined with Benzatropine.
DB12212
The metabolism of Landiolol can be decreased when combined with Benzatropine.
DB12752
The metabolism of Bucindolol can be decreased when combined with Benzatropine.
DB13443
The metabolism of Esatenolol can be decreased when combined with Benzatropine.
DB13508
The metabolism of Cloranolol can be decreased when combined with Benzatropine.
DB13530
The metabolism of Mepindolol can be decreased when combined with Benzatropine.
DB13757
The metabolism of Epanolol can be decreased when combined with Benzatropine.
DB13775
The metabolism of Tertatolol can be decreased when combined with Benzatropine.
DB06506
The metabolism of Repinotan can be decreased when combined with Benzatropine.
DB09173
The metabolism of Butyrfentanyl can be decreased when combined with Benzatropine.
DB11757
The metabolism of Istradefylline can be decreased when combined with Benzatropine.
DB01410
The metabolism of Ciclesonide can be decreased when combined with Benzatropine.
DB04889
The metabolism of Bicifadine can be decreased when combined with Benzatropine.
DB00530
The metabolism of Erlotinib can be decreased when combined with Benzatropine.
DB00637
The metabolism of Astemizole can be decreased when combined with Benzatropine.
DB11963
The metabolism of Benzatropine can be decreased when combined with Dacomitinib.
DB00675
The metabolism of Benzatropine can be decreased when combined with Tamoxifen.
DB13874
The metabolism of Benzatropine can be decreased when combined with Enasidenib.
DB05109
The metabolism of Trabectedin can be decreased when combined with Benzatropine.
DB08901
The metabolism of Ponatinib can be decreased when combined with Benzatropine.
DB00277
The metabolism of Theophylline can be decreased when combined with Benzatropine.
DB00489
The metabolism of Sotalol can be decreased when combined with Benzatropine.
DB01035
The metabolism of Procainamide can be decreased when combined with Benzatropine.
DB01195
The metabolism of Flecainide can be decreased when combined with Benzatropine.
DB00321
The metabolism of Benzatropine can be decreased when combined with Amitriptyline.
DB00540
The metabolism of Benzatropine can be decreased when combined with Nortriptyline.
DB00575
The metabolism of Benzatropine can be decreased when combined with Clonidine.
DB00726
The metabolism of Benzatropine can be decreased when combined with Trimipramine.
DB01242
The metabolism of Benzatropine can be decreased when combined with Clomipramine.
DB01235
The absorption of Levodopa can be decreased when combined with Benzatropine.
DB00455
Benzatropine may increase the anticholinergic activities of Loratadine.
DB00005
The metabolism of Benzatropine can be increased when combined with Etanercept.
DB00026
The metabolism of Benzatropine can be increased when combined with Anakinra.
DB00051
The metabolism of Benzatropine can be increased when combined with Adalimumab.
DB00065
The metabolism of Benzatropine can be increased when combined with Infliximab.
DB01281
The metabolism of Benzatropine can be increased when combined with Abatacept.
DB04956
The metabolism of Benzatropine can be increased when combined with Afelimomab.
DB05676
The metabolism of Benzatropine can be increased when combined with Apremilast.
DB06168
The metabolism of Benzatropine can be increased when combined with Canakinumab.
DB06273
The metabolism of Benzatropine can be increased when combined with Tocilizumab.
DB06372
The metabolism of Benzatropine can be increased when combined with Rilonacept.
DB06674
The metabolism of Benzatropine can be increased when combined with Golimumab.
DB08904
The metabolism of Benzatropine can be increased when combined with Certolizumab pegol.
DB09029
The metabolism of Benzatropine can be increased when combined with Secukinumab.
DB09036
The metabolism of Benzatropine can be increased when combined with Siltuximab.
DB14724
The metabolism of Benzatropine can be increased when combined with Emapalumab.
DB00217
The risk or severity of Tachycardia can be increased when Bethanidine is combined with Benzatropine.
DB00221
The risk or severity of Tachycardia can be increased when Isoetharine is combined with Benzatropine.
DB00368
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Norepinephrine.
DB00388
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Phenylephrine.
DB00397
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Phenylpropanolamine.
DB00610
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Metaraminol.
DB00629
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Guanabenz.
DB00668
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Epinephrine.
DB00723
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Methoxamine.
DB00816
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Orciprenaline.
DB00830
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Phenmetrazine.
DB00867
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Ritodrine.
DB00901
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Bitolterol.
DB00935
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Oxymetazoline.
DB01064
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Isoprenaline.
DB01102
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Arbutamine.
DB01291
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Pirbuterol.
DB01363
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Ephedra sinica root.
DB01364
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Ephedrine.
DB01366
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Procaterol.
DB01407
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Clenbuterol.
DB01579
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Phendimetrazine.
DB05395
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Amibegron.
DB06152
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Nylidrin.
DB06190
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Solabegron.
DB06694
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Xylometazoline.
DB06706
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Isometheptene.
DB06707
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Levonordefrin.
DB06711
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Naphazoline.
DB06764
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Tetryzoline.
DB06814
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Protokylol.
DB08841
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Tyramine.
DB08925
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Adrafinil.
DB08941
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Isoxsuprine.
DB08957
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Hexoprenaline.
DB08985
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Etilefrine.
DB09202
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Cirazoline.
DB09203
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Synephrine.
DB09242
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Moxonidine.
DB09273
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Doxofylline.
DB11124
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Racepinephrine.
DB11373
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Amitraz.
DB11541
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Ractopamine.
DB11738
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Rilmenidine.
DB11871
The risk or severity of Tachycardia can be increased when Benzatropine is combined with PF-00610355.
DB12100
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Abediterol.
DB12248
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Tulobuterol.
DB12313
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Dopexamine.
DB12779
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Higenamine.
DB12846
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Reproterol.
DB13064
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Tramazoline.
DB13251
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Octopamine.
DB13341
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Fenozolone.
DB13378
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Norfenefrine.
DB13398
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Oxyfedrine.
DB13559
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Rimiterol.
DB13692
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Tretoquinol.
DB13777
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Prenalterol.
DB13781
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Xamoterol.
DB13852
The risk or severity of Tachycardia can be increased when Benzatropine is combined with Mefenorex.
DB00211
The risk or severity of Tachycardia can be increased when Midodrine is combined with Benzatropine.
DB13074
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Benzatropine.
DB01233
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Benzatropine.
DB06077
The risk or severity of adverse effects can be increased when Lumateperone is combined with Benzatropine.
DB00334
The risk or severity of adverse effects can be increased when Olanzapine is combined with Benzatropine.
DB00353
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Benzatropine.
DB00363
The risk or severity of adverse effects can be increased when Clozapine is combined with Benzatropine.
DB00372
The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Benzatropine.
DB00391
The risk or severity of adverse effects can be increased when Sulpiride is combined with Benzatropine.
DB00408
The risk or severity of adverse effects can be increased when Loxapine is combined with Benzatropine.
DB00409
The risk or severity of adverse effects can be increased when Remoxipride is combined with Benzatropine.
DB00420
The risk or severity of adverse effects can be increased when Promazine is combined with Benzatropine.
DB00433
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Benzatropine.
DB00450
The risk or severity of adverse effects can be increased when Droperidol is combined with Benzatropine.
DB00477
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Benzatropine.
DB00490
The risk or severity of adverse effects can be increased when Buspirone is combined with Benzatropine.
DB00502
The risk or severity of adverse effects can be increased when Haloperidol is combined with Benzatropine.
DB00508
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Benzatropine.
DB00543
The risk or severity of adverse effects can be increased when Amoxapine is combined with Benzatropine.
DB00589
The risk or severity of adverse effects can be increased when Lisuride is combined with Benzatropine.
DB00623
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benzatropine.
DB00679
The risk or severity of adverse effects can be increased when Thioridazine is combined with Benzatropine.
DB00734
The risk or severity of adverse effects can be increased when Risperidone is combined with Benzatropine.
DB00777
The risk or severity of adverse effects can be increased when Propiomazine is combined with Benzatropine.
DB00831
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Benzatropine.
DB00850
The risk or severity of adverse effects can be increased when Perphenazine is combined with Benzatropine.
DB00875
The risk or severity of adverse effects can be increased when Flupentixol is combined with Benzatropine.
DB00933
The risk or severity of adverse effects can be increased when Mesoridazine is combined with Benzatropine.
DB01038
The risk or severity of adverse effects can be increased when Carphenazine is combined with Benzatropine.
DB01063
The risk or severity of adverse effects can be increased when Acetophenazine is combined with Benzatropine.
DB01069
The risk or severity of adverse effects can be increased when Promethazine is combined with Benzatropine.
DB01100
The risk or severity of adverse effects can be increased when Pimozide is combined with Benzatropine.
DB01184
The risk or severity of adverse effects can be increased when Domperidone is combined with Benzatropine.
DB01224
The risk or severity of adverse effects can be increased when Quetiapine is combined with Benzatropine.
DB01238
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Benzatropine.
DB01239
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Benzatropine.
DB01267
The risk or severity of adverse effects can be increased when Paliperidone is combined with Benzatropine.
DB01392
The risk or severity of adverse effects can be increased when Yohimbine is combined with Benzatropine.
DB01403
The risk or severity of adverse effects can be increased when Methotrimeprazine is combined with Benzatropine.
DB01425
The risk or severity of adverse effects can be increased when Alizapride is combined with Benzatropine.
DB01608
The risk or severity of adverse effects can be increased when Periciazine is combined with Benzatropine.
DB01614
The risk or severity of adverse effects can be increased when Acepromazine is combined with Benzatropine.
DB01615
The risk or severity of adverse effects can be increased when Aceprometazine is combined with Benzatropine.
DB01618
The risk or severity of adverse effects can be increased when Molindone is combined with Benzatropine.
DB01621
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Benzatropine.
DB01622
The risk or severity of adverse effects can be increased when Thioproperazine is combined with Benzatropine.
DB01623
The risk or severity of adverse effects can be increased when Thiothixene is combined with Benzatropine.
DB01624
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Benzatropine.
DB04842
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Benzatropine.
DB04946
The risk or severity of adverse effects can be increased when Iloperidone is combined with Benzatropine.
DB06109
The risk or severity of adverse effects can be increased when YKP-1358 is combined with Benzatropine.
DB06144
The risk or severity of adverse effects can be increased when Sertindole is combined with Benzatropine.
DB06216
The risk or severity of adverse effects can be increased when Asenapine is combined with Benzatropine.
DB06288
The risk or severity of adverse effects can be increased when Amisulpride is combined with Benzatropine.
DB08815
The risk or severity of adverse effects can be increased when Lurasidone is combined with Benzatropine.
DB08922
The risk or severity of adverse effects can be increased when Perospirone is combined with Benzatropine.
DB09018
The risk or severity of adverse effects can be increased when Bromopride is combined with Benzatropine.
DB09207
The risk or severity of adverse effects can be increased when AS-8112 is combined with Benzatropine.
DB09223
The risk or severity of adverse effects can be increased when Blonanserin is combined with Benzatropine.
DB09224
The risk or severity of adverse effects can be increased when Melperone is combined with Benzatropine.
DB09225
The risk or severity of adverse effects can be increased when Zotepine is combined with Benzatropine.
DB09286
The risk or severity of adverse effects can be increased when Pipamperone is combined with Benzatropine.
DB11376
The risk or severity of adverse effects can be increased when Azaperone is combined with Benzatropine.
DB12093
The risk or severity of adverse effects can be increased when Tetrahydropalmatine is combined with Benzatropine.
DB12273
The risk or severity of adverse effects can be increased when Ecopipam is combined with Benzatropine.
DB12518
The risk or severity of adverse effects can be increased when Raclopride is combined with Benzatropine.
DB12579
The risk or severity of adverse effects can be increased when JNJ-37822681 is combined with Benzatropine.
DB12710
The risk or severity of adverse effects can be increased when Perazine is combined with Benzatropine.
DB12867
The risk or severity of adverse effects can be increased when Benperidol is combined with Benzatropine.
DB13025
The risk or severity of adverse effects can be increased when Tiapride is combined with Benzatropine.
DB13273
The risk or severity of adverse effects can be increased when Sultopride is combined with Benzatropine.
DB13511
The risk or severity of adverse effects can be increased when Clebopride is combined with Benzatropine.
DB13552
The risk or severity of adverse effects can be increased when Trifluperidol is combined with Benzatropine.
DB13791
The risk or severity of adverse effects can be increased when Penfluridol is combined with Benzatropine.
DB13841
The risk or severity of adverse effects can be increased when Clopenthixol is combined with Benzatropine.
DB15167
The risk or severity of adverse effects can be increased when Fallypride is combined with Benzatropine.
DB15492
The risk or severity of adverse effects can be increased when Eticlopride is combined with Benzatropine.
DB14754
The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Benzatropine.
DB00656
The risk or severity of QTc prolongation can be increased when Trazodone is combined with Benzatropine.
DB00843
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Donepezil.
DB11986
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Entrectinib.
DB12825
Lefamulin may increase the QTc-prolonging activities of Benzatropine.
DB01175
The serum concentration of Escitalopram can be increased when it is combined with Benzatropine.
DB04855
The metabolism of Dronedarone can be decreased when combined with Benzatropine.
DB15066
The serum concentration of Benzatropine can be increased when it is combined with Givosiran.
DB00243
The serum concentration of Benzatropine can be increased when it is combined with Ranolazine.
DB00557
The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Benzatropine.
DB00246
The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Benzatropine.
DB00472
The serum concentration of Benzatropine can be increased when it is combined with Fluoxetine.
DB14881
The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Benzatropine is combined with Oliceridine.